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Rapid degradation of certain short lived "timing" proteinsis
an effective mechanism for cellstocontrol important regulatory
pathways. Themechanismsbywhichregulatoryproteases
recognize their substrates are not well understood.Escherichiacoli
Lon,an energy dependent proteasehighlyconservedin many
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RcsA, a regulator of capsule synthesis, when present in levels
high enough tosaturate Lon, cannot protect SulA, a cell division
inhibitor, from being degraded.These observations suggest Lon
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different affinities of these substrates might relate to the role these
substrates play in thecell:stabilization of RcsA leads to a non-
lethal phenotype(capsule),whilestabilizationof SulA leadsto
lethalfilamentation.
Redacted for PrivacyTo further examine protease/substrateinteractions,targeted
mutagenesis was employed toselect for mutations in rcsA which
giverisetomutant RcsA protein no longer degraded by Lon
protease.Two mutants with an increased half-life in the presence
of Lon were identified.Their mutationsfallinto the C-terminal
regionof RcsA,supportingthehypothesisthatthisregionis
involved in the interaction of RcsA with Lon.
Stabilization of RcsA was dependent on its partner RcsB; the
interaction of RcsA with RcsB is believed to protect RcsA from Lon
dependentdegradation.However,itwasshownthatrcsA
expression is enhanced in the presence of RcsB, and RcsA protein
cannot be detected instrains mutant for RcsB in the presence or
absence of Lon.Furthermore, rcsA expression was shown to be
activated by RcsA itself: rcsA::lacZexpression is low in the absence
of RcsA.A conserved 25 by motif, designated "RcsA-Box" was
identified inthe promoter region of the rcsA and capsule (cps)
genes.This motif was shown to be a likely candidate for RcsA
binding: high level expression of both cps::lacZ and rcsA::lacZ
fusions was shown to be dependent on the presence of the "RcsA-
Box".
Thesestudiesexpandtheunderstandingofthespecific
interactionsbetweenregulatoryproteasesandtheirtargets,
specifically as they relates to complex regulatory networks.© Copyright by Wolfgang Ebel
JUNE 19, 1997
All Rights ReservedShort Lived Bacterial Regulatory Proteins: What Determines Their
Fate?
by
Wolfgang Ebel
A Dissertation
submittedto
Oregon State University
In Partial Fulfillment of
the Requirements for the
Degree of
Doctor of Philosophy
Completed June 19, 1997
Commencement June1998Doctor of Philosophy dissertation of Wolfgang Ebel presented on
June 19,1997.
APPROVED:
Major Professor, representing/ Microbiology
Department of Microbi
Dean ofduate School
I understand that my thesis will become part of the permanent
collection of Oregon State University libraries.My signature below
authorizes release of my dissertation to any reader upon request.
lfgang Ebel, Author
Redacted for Privacy
Redacted for Privacy
Redacted for Privacy
Redacted for PrivacyACKNOWLEDGMENTS
To name allthe people who have been instrumental in
helping me complete my goal would require almost as much space
asittook towrite my dissertation.AlthoughI am unableto
mention everyone,I am grateful for their contributions.
OnaprofessionallevelIhavetofirstandforemost
acknowledge my advisor,mentor andbiggestsupporterJanine
Trempy.Itwas her enthusiasmthatsparked my interestin
science and has helped me fulfill my goal.Her continued support
andadvicehasguided me throughoutthe"graduateschool
adventure".Thanks!
I would like to thank my committee members Dr. Bottom ley,
Dr. Daeschel, Dr. Giovannoni and Dr. Ho for their time and support
(a special thanks to Dr. Bottom ley for digging out my car at the
beach in Newport!).
Thank you to all the members of the Trempy lab: Gary, Karen,
Eric, Drew, Mary-Jane, Rocky, Jim, Don, Jannelle, Beth, Jessica, Scott,
Erica. Johanna, Miriam, Armelle, Tove, Howardfor listening to my
thoughts and ideas,sometimes my German music andfornot
throwing out the picture of blood sausage, pig belly, sauerkraut and
wheat beer on my desk!
A big thank you to Mary Burke, Susan Williams and Janine
Trempy for helping me learn to enjoy teaching as much as they do,
and to the rest of the faculty, especially Dr. Leong, Dr. Sandine and
Dr. Fryer for their time and willingness to listen and help.On a personal levelIwant to acknowledge my wife Amy.
Although you don't share my enthusiasm for laboratory research,
you have spent almost as much time in the lab asI have.Thank
you for your love and support, I couldn't have done it without you!
I want to thank my parents for supporting me in my decision
to stay in the US to finish my graduate degree.I know you were
worriedthatbasketballwas on my mind whenImadethis
decision.Trust me, it came in a close second!
A thank you toall my roommates over the years (Rachel,
Dave,Ann,Johanna,Iki,Christian,Thilo,Anette,Marcelino,
Quitterie, Dan, Mat and Thomas) for putting up with me.
Finally, I would like to thank all the friends I have made over
theyearsat OSU for being theretotalk,have fun and make
Corvallis such a great place to live!TABLE OF CONTENTS
Page
Introduction And Literature Review 1
Proteases As Regulators 1
General Mechanisms Of Substrate Recognition 3
Lon Protease 6
Identification Of Lon Protease In E. coli 6
Structure And Function Of The E. coli Lon Protease 8
The Proteolytic Mechanism 10
Lon Protease In E. coli And Other Organisms 16
E. coli Lon Protease And Its Substrates 29
RcsA, Regulator Of Capsule Synthesis 29
Su1A, Inhibitor Of Cell Division 30
AN Protein 32
CcdA, Control Of Cell Death Protein 33
Abnormal Proteins And Proteins Without Partners34
Regulation Of Capsule Gene Expression In E. coli 3 4
Research Objectives 39
Materials And Methods 40
Reagents 40
Strains, Media And Growth Conditions 40
Nucleic Acid Extractions 51
Total Chromosomal DNA 51
Small Scale Plasmid Preparation 52
Large Scale Plasmid Preparation 53
Total RNA Preparation 55
Ribonuclease Protection Assay 55
Preparation Of Phage Lysates 56
P1 virLysates 56
X Lysates 57TABLE OF CONTENTS (Continued)
Page
Strain Constructions 57
Transductions 57
Competent Cells And Transformations 58
Transposon Mutagenesis 59
Detection Of RcsA And RcsA* 60
RcsA And RcsA* Turnover And Half-Life Determination 61
P-Galactosidase Assay 62
Construction Of rcsA::lacZ And cps::lacZ Promoter Fusions63
Targeted Mutagenesis Of The rcsA Gene 67
Determination Of rcsA * Sequences 67
Results 69
Saturation Of Lon Protease 69
Targeted Mutagenesis Of rcsA 7 2
RcsA And RcsA* Turnover 80
Sequencing Of rcsA* Mutant Alleles 87
Detection Of RcsA* In A lon+ rcsB- Strain 91
rcsA Expression Is Activated In The Presence
Of RcsA Protein 92
rcsA Transcription Is Increased In Mon Strains 97
rcsA90::lacZ Expression Is Regulated
By Lon, RcsB And H-NS 99
RcsA Protein Can Be Detected In A
Mon rcsB-hns- Strain 1 0 1
rcsA Expression Is Increased In Ion+ rcsA* Strains 10 5
Identification Of A Putative "RcsA-box" 10 7
Effects Of The "RcsA-Box" On Expression Of rcsA And cps. 110TABLE OF CONTENTS (Continued)
Discussion And Summary
Lon Recognizes Su1A With A Higher Affinity Than RcsA
A Single Copy Approach, Targeted Mutagenesis,
Page
1 1 4
1 14
Allows For The Identification Of RcsA Protein
Resistant To Lon Dependent Degradation 11 7
rcsA Expression Is Regulated By RcsA Protein 12 8
A Conserved Sequence Motif Can Be Identified
In The rcsA And cps Promoter Regions 13 2
Involvement Of RcsB And H-NS In rcsA Expression 13 5
Summary 13 8
Bibliography 140
Appendix 15 6
Biographical Information 1 5 6LIST OF FIGURES
Figure
1.Location of important structural features of Lon
2.Model of capsule gene regulation in E. coli
Page
9
36
3.Schematic representation of targeted mutagenesis 73
4.Grouping of RcsA* strains according to their levels of
cpsBio::lacZ activity in lon+ cells 75
5.Western blot detection of RcsA* in Ion+ cells 77
6.RcsA* and RcsA turnover in vivo 82
7.RcsA and RcsA* stabilityand half-life determination 85
8.RcsA is involved in regulating its own expression 95
9.Detection of RcsA in rcsB-lins-lon- strains 102
10.Identification of a putative "RcsA-Box" 108LIST OF TABLES
Table Page
1.Lon protease in pro- and eukaryotes 18
2.Bacterial strains, plasmids and phages used in this study 41
3.Saturation of Lon protease with RcsA does not protect
SulA from Lon dependent degradation 7 0
4.Summary of data gathered for six rcsA* mutant strains8 8
5.Summary of nucleotide and amino acid changes
associated with rcsA * mutants 9 1
6.Effects of mutations in Ion, rcsB and has on the
expression of the rcsA90::lacZ transcriptional
fusion and the production of capsule 100
7.rcsA expression is increased in lon+ rcsA * strains 10 6
8.Effect of the putative "RcsA-Box" on the
expression of rcsA::lacZ and cps::lacZ operon fusions 1 1 1DEDICATION
I would like to dedicate this dissertation to
the memory of my late grandfather Heinrich Schmitt.He never
understood why I left Germany to study in the US.Well, here is
the reason.I know if you could be here with me today, you would
understand!SHORT LIVED BACTERIAL REGULATORY PROTEINS, WHAT
DETERMINES THEIR FATE?
Introduction And LiteratureReview
ProteasesAsRegulators
Foralllivingcells,theabilitytoadapttoachanging
environment iscrucial for survival and/or development.In order
to respond correctly to a change inits environment, a cell has to
alter the availability and/or activity of many key regulators which
mediate thecontrol over metabolic and developmental pathways
necessary for cell survival.The degradation of specific proteins by
regulatory proteasesasa means to rapidly control thelevels of
certain proteins and ultimately the cellular processes they govern
has been a research field gaining more and more interest.While
most cellular proteins are stable in vivo (40, 41), certain regulatory
proteins are degraded rapidly.The ability of a cell to selectively
and timely degrade thesespecificproteins,often referredtoas
"timing proteins" (44), allows for an added layer of regulation of
cellularprocessesinadditiontothe moreclassicalregulatory
processessuchastranscription,translationandcovalent
modification.The utilizationof proteasestoeliminate proteins
from cellshasseveraladvantages.Complete degradation of a
regulatory protein effectively eliminates it from the cell, in contrast2
to transcriptional regulation, where appearance of new proteins can
be regulated but already existing proteins persist in the cell.This
may constitutea problemiftheprotein, whose functionisno
longer needed, is either toxic or interferes with the next step in a
regulatorycascade.Theeliminationofproteins
regulatingcertaindevelopmentalfunctionscan
checkpoint for the progression through this pathway
regulators are degraded the cellis committed to this
such cases degradation may offer advantages over
since the amino acids of the obsolete protein can be
involvedin
constitutea
and once the
pathway.In
modification,
recycled into
newly synthesized proteins.Inadditiontotemporal regulation,
proteolytic mechanisms can allow forspatial regulation by being
active in certain tissues or, in the case of unicellular organisms, by
selectivepartitioningduringadevelopmental process(86,135).
Formanypathways,severalmechanismsofregulationare
employedsimultaneously,probablyallowingcellstofine-tune
processes with all regulatory tricks the cell has at its disposal.
Inadditiontothedegradation of specificproteins, many
regulatory proteases have evolved to degrade "abnormal" proteins,
those proteins which have been altered due totranscriptionalor
translational errors, proteins that are misfolded due to heat stress,
membersofmultiproteincomplexessynthesizedinabnormal
ratios ("proteins without partners" (48)) or proteins which were not
properlytransported.
Oneofthedistinguishingfeaturesoftheseregulatory
proteases isthe processcivity of degradation and the energy (ATP)3
requirement.The reasonsforthisenergy requirementarenot
completely understood.ATP isnot requiredfor peptide bond
cleavage and itisbelieved that the energy requirement isrelated
toeither substrate recognition or unfolding of thesubstrates(see
pg.11).Since regulatory proteasesare processive, degradation
productsaregenerally not observedinvivo.This processcivity
might indicatethattheseproteasesdo not recognizeasingle
cleavagesiteon theirsubstrates,but rather recognizeacertain
featureof thesubstrateand subsequently cleave multiplesites
within thesubstrates.Two energy dependent proteases, Lon and
Clp, first identified in E.coli,are highly conserved between pro-
and eukaryotes(51).Inadditiontothese conserved proteases,
severalotherenergy dependent proteaseshave beenidentified
(rev. in 43, 48).
General Mechanisms Of Substrate Recognition
One of the key questions concerning regulatory proteasesis
theability of these enzymes to recognize their substrates among
the hundreds of other, non-substrate proteins in a cell.Itisthis
interaction, between the protease and itssubstrates that allows this
regulatory mechanism to be functional and efficient.
Substraterecognitioncanbeachieved byeitherof two
mechanisms:thedegradationsignalresideswithinthesubstrate
protein directlyinthe form of a primary amino acid sequence
motif and is specific for a given substrate and its cognate protease,4
or a substrate protein is marked for degradation by the addition of
a recognition tag.
In the latter case the protease is recognizing the tag rather
than the protein, and the specificity of the mechanism depends on
the enzymes adding the tagtothesubstrates.The best studied
tagging mechanismisfound inalleukaryotes and involvesthe
addition of several ubiquitin moieties, a small, highly conserved 8-
kDa protein, to the e-amino side chain of lysine residues of the
targetprotein.Ubiquitintaggingisamultistepprocessthat
involvesatleast two enzymes (ubiquitin-activating enzyme [El],
ubiquitin-conjugating enzyme [E2]) and incertaincasesathird
enzyme,ubiquitin-proteinligase[E3].Theubiquitintagged
proteinsarerapidly degraded bythemulti-catalyticproteasome
(or 26S proteasome) (103).The signal(s) for the ubiquitination of
proteinsarestillnot completely understood but certainproteins
have been shown to follow the N-end rule: the presence of amino
acids with bulky side chains (Arg, Lys, His, Phe, Trp, Tyr, Leu) at
the N-terminus of a protein in addition to a lysine residue in close
proximityissufficientfortheubiquitinationandsubsequent
degradation of certain proteins, since normally stable proteinscan
be convertedintounstableproteinsthroughtheadditionofa
destabilizing, N-terminal residue (5, 42, 125, 126).The specificity
of the ubiquitin tagging mechanism with respect to other,non N-
endrulesubstrates,apparentlyismediatedthroughspecific
protein/proteininteractionsofspecificE1 -E3swiththeir
substrates.An example of the controlled degradation of specific5
"timing"proteinsviatheubiquitinpathwayisthespecific
degradation of cyclins during the cell cycle of eukaryotic organisms
(120).Another intriguing example for this specificity is a ubiquitin
protein ligase identified from Human Papilloma Virus (HPV) which
specificallyinteractswiththe tumor suppressor p53toinduce
rapiddegradationof p53in HPV infectedcells,leadingto
uncontrolled cell proliferation and ultimately to cancer (93).
Recently,Sauer and coworkers haveidentifiedatagging
mechanism in E. coli (62).This mechanism has apparently evolved
toaddadegradationsignaltopolypeptidessynthesized from
defective mRNA molecules.If during translation the ribosome is
stalled on a defective mRNA, due to, for instance, the lack ofa stop
codon, the ribosome cannot be released and translation isarrested.
Sauer and coworkers demonstrated that in order for translation to
proceed, the stalled ribosome switches to a differentmessage.This
new message is a small stable RNA molecule encoded by the ssrA
gene and known as 10Sa RNA.A portion of the 362 nucleotide
10Sa RNA molecule is able to fold into a tRNA-like structure which
can be charged with alanine.Once the stalled ribosome switches to
the 10Sa RNA, alanine is incorporated into the nascent polypeptide
chain and translation switches over to the region of the 10Sa RNA
molecule which encodes thepeptidetag(sequence of thetag:
AANDENYALAA) (62).Once the tagged protein is released,itis
degradedbyproteasesspecificallyrecognizingtheC-terminal
peptide tag.At least two such proteases exist, the periplasmic Tsp
protease(tailspecificprotease)(95)andanunidentified6
cytoplasmic protease (C1pXP has been implicated (43), but no data
has been published).Existence of the latter can be inferred from
thefactthatnon-exported,C-terminallytaggedproteinsare
degradedintsp-strains(62).Tsp proteaseisneither energy
dependent, nor has it been implicated in the degradation of specific
proteins.However, the possibility exists that the levels of proteins
which encode the C-terminal tagas part of their normal coding
sequence are regulated by tailspecific proteases.
Recognition of aspecific amino acid motif has not been
conclusively demonstrated asa mechanism of substrateselection
forany of theenergy dependent proteases.However,theC-
terminal end of several substrates of the E. coli ClpXP protease are
similar (43) and might constitutea sequence motif recognized by
thisprotease.
For severalother regulatory proteases,specificallythe Lon
protease,themechanism ofsubstrateselectionhasnotbeen
defined and remains the focus of intensive investigation.
LonProtease
Identification Of Lon Protease In E.coli
Lon protease was one of the first energy dependent proteases
to be identified and characterized.Mutations in the E. coli Ion gene
were independentlyidentifiedgeneticallyandbiochemically by7
several investigators.Markovitz identified a mutation in E.coli
which leadsto the overproduction of capsular polysaccharide and
termedthismutation capR (for capsule)(70).Theriot, et al.
isolatedE.coli mutantswhichformedlongfilamentsafter
treatment with UV light and designated the locus responsible for
this phenotype ion (54).In addition Apte, et al. and Zipser, et al.
identified mutationsthatstabilizedP-galactosidasefragmentsin
E.coli, designated degR and degT, respectively (3,12) and showed
that they mapped tothe ionlocus.Goldberg and coworkers
identified nine proteolyticactivities from E.coli protein extracts
based on theirabilityto degrade radio-labeled casein,globin or
insulin in vitro. (111)The activities were named in the order they
eluted from DEAE-cellulose columns Do, Re, Mi, Fa, So, La, Ti, Pi and
Ci.Based on itsinhibition by diisopropyl fluorophosphate (DFP)
and stimulation by ATP, protease La was identified as an energy
dependentserineprotease.Work byMarkovitz, et al.and
Goldberg, et al.unifiedthefieldbydemonstratingthatthe
pleiotropiceffectsof these mutants were duetothelack of a
proteolytic activity encoded by the ion gene, whose gehe product is
identical to protease La (15,17).
Today it has become clear that Lon protease is one of the
mostimportantenergydependentproteasesinE.coli.The
mutations observedinion mutant cells have been explained as
defectsinthedegradationofseveralspecificandnon-specific
proteins.Lon proteaseisthe dominant protease involved in the
degradation of abnormal proteins.These proteins arise as a result8
of heatstressortheadditionof amino acidanalogs suchas
canavanyl to the growth medium.In Ion mutant cells,degradation
of abnormal proteinsisreduced by approximately 50-60%.In
addition to these non-specific proteins,it has been shown that Lon
regulatesseveralimportant pathways by degradingcertainshort
lived,regulatory proteins.The most notable phenotypes of Ion
mutantcells,sensitivitytoDNAdamagingagentsand
overproduction of capsular polysaccharide, have been attributedto
thestabilizationof the normally shortlived regulatory proteins
Su1A and RcsA, respectively.
Structure And Function Of The E. coli Lon Protease
In E.coli the Lon protease is encoded by the Ion gene which
maps at 10 minutes on the E.coli chromosome.The gene was
sequenced by Chin, et al. (16) and found to encode a protein of 783
amino acids (87 kDa).This issomewhat smaller from the apparent
molecular weight determined by SDS-PAGE analysis (91-94 kDa)
(17,136).The native enzyme, as determined by gel filtration, has
amolecular weight of approximately 450 kDa and,therefore,
appears to be a homo-tetramer (17).The N-terminal amino acid
sequence
isoelectric
predictedfromthe DNA sequence,thepredicted
point and amino acid composition
previouslyreportedexperimentalresults.
correspond well with
Sequenceanalysis
identified several important features of Lon protease (Figure1).as residue#
9
1 211--270346--425 679 783
Met Ser
= Region encoding ATP binding domain;
= Region encoding acidic amino acids;
= Region encoding basic amino acids;
= Serine active site.
Figure 1. Location of important structural features of Lon
Theseincludeasingle,wellconserved ATPbindingdomain
between amino acid 346 and 425, a segment containing a stretch of
basic amino acids, followed by a stretch of acidic amino acids and
another stretch of basic amino acids (amino acids 211-272).The
intact ATP binding domain is crucial for Lon function and mutants
with changes inthis domain, abolishing ATP binding, have been
showntohavelostproteaseactivityagainstproteinsubstrates
(26). Also, an inhibitor of Lon protease, the bacteriophage T4 PinA
protein(99) was shown tointerfere with ATP hydrolysis(43).
Analysis of the ion promoter region identifieda consensus heat-
shock promoter sequence, confirming observations that indicatean10
increased content of Lon protease in cells subjected to heat shock
(36,82).The fact that Lon activity can be inhibited by serine
proteaseinhibitorsledtothesuggestionthat Lonisaserine
protease (130,131).Based on the sequence similarity surrounding
serineresidue 679tootherserineproteases,thisresidue was
hypothesized to be the catalytically active residue.This notion was
confirmedbysitedirectedmutagenesis,demonstratingthata
serine 679 to alanine mutant lacks protease activity against specific
substrates such as RcsA and Su1A as judged by the phenotypes
resulting from expression of this allele from a plasmid in lon- cells
compared to cells expressing a functional ion gene from a plasmid
inthe same strain(2).An additional feature of Lon protease,
which has not yet been linked toits function,isits DNA binding
activity.Markovitz, et al.demonstratedthisapparentlynon
specific DNA binding activity and utilized this activity to purify Lon
protease(136).Recently,Markovitz, et al.showedsequence
specific binding of E. coli Lon protease to the peri-etssite of the
human immunodeficiencyvirustype2(HIV-2) enhancer(29).
Several investigators have hypothesized that DNA binding of Lon
protease might be involved in itssubstrate recognition.
TheProteolyticMechanism
Initialstudiesonthemechanism ofproteolysis,energy
requirement and substrate binding of E. coli Lon proteasewere
based on in vitro degradation of non physiological substrates such11
as casein, globin and small fluorogenic peptides.Based on these
data,Goldberg, et al.proposedamodelforLon-dependent
degradationofproteins(130-132,reviewedin72).Briefly,
substrate bindsto an allostericsite(different from thecatalytic
site) on one of the protease subunits which has ADP bound toits
ATP bindingsite.The binding of substrate promotes exchange
between ADP and ATP, which inturn induces a conformational
changeintheactivesite(fromclosedtoopen)allowingthe
substratetoenter and be cleavedatan appropriatesite.ATP
hydrolysis returns the activesiteto the closed (ADP bound) state
and induces the release of the cleaved portion of the substrate.
Ifthesubstrateremains boundtotheallostericsiteit
promotes a second ATP/ADP exchange with the difference being,
that no protein is bound in the active site.This continued binding
of the substrate to the allostericsite of one subunit isinhibitory,
and in order for the enzyme to continue the degradation process,
thesubstrate must be released or moved fora second cleavage
step.
Since Lon substrates bind to subunits with ADP bound to the
nucleotide binding site with higher affinity, hydrolysis of ATP to
ADP onaneighboring subunit would promote the"switch"or
translocationof thesubstrate from thesubunit withtheclosed
allostericsite (ATP bound) tothesubunit with the open (ADP
bound) allostericsite and,if a suitable cleavage siteispresent a
second proteolytic cleavage.Subsequent rounds of ATP hydrolysis
and proteolyticcleavage would then account forthe processive12
nature of protein degradation seen for Lon substrates.This model
accounts for the energy requirements and for the processive nature
of Lon dependent degradation.Inthis model substrate proteins
need tofulfill two requirements, binding totheallostericsitein
addition to the presence of a suitable peptide bond recognized by
the catalytic site.These requirements can explain the selectivity of
Lon protease and the fact thatinvitrostudieshaveidentified
severalsuitablecleavagesiteswhosenaturealone wouldnot
account for the selectivity of the protease (71, 124).
In vitro studies with the purified substrates XN protein (71),
CcdA (124) and a maltose binding protein-SulA fusion (MBP-SulA)
protein (104)support theoverallnatureof thismodel.These
studies further demonstrated that Lon protease directly recognizes
itssubstratewithoutfurtherneedofa"tagging"mechanism.
Substrate recognition signals reside within thesubstrates and are
specificallyrecognized bytheprotease.Van Melderen, et al.,
workingwith CcdA andatruncatedversionofthisprotein
consisting of 41amino acidsof theC-terminal end (CcdA41),
demonstratedthatdegradationofthewild-type CcdA protein
requires ATP hydrolysis, while the degradation of thetruncated
form of this protein only required the presence, but not hydrolysis
of ATP since degradation was observed in the presence of anon-
hydrolyzable ATP analog.These datasupport thenotionthat
nucleotide binding is required to "open" the catalytic active site of
the protease and that ATP hydrolysisisnot required for peptide
bond cleavage.The in vitro experiments have not led to a clear13
definition of the role of ATP hydrolysis, however analysis of the
differencesinsecondarystructurebetween CcdA and CcdA41
indicatesthatthesecondary structureof thetruncated formis
much lessstable and thatthe N-terminal domain missing from
CcdA41 might interact with the C-terminal portion of the protein.
These findings may indicate a role for ATP hydrolysis in unfolding
complex secondary structures of substrate proteins, giving Lon a
chaperon-likefunction.Thisnotionissupportedbyfindings
reportedbyRep, et al.(85)demonstratingtheabilityof an
overproduced mutant Lon protease, deficient in protease function,
tocomplementcertainphenotypesofaAfg3p/Rcalp protease
double mutant in the yeast Saccharomycescerevisiae.These yeast
double mutantsaredefectiveinrespirationdependent growth,
degradationofmitochondrialproteinsandassemblyof
mitochondrial inner membrane complexes.Overproduction of a
protease deficient Lon mutant protein, but not overproduction of
an ATPase deficient Lon mutant protein, could restore respiration
dependent growthandproteincomplexassembly,butneither
mutant complemented the degradation defects seen inthe mutant
yeast strain.These findings indicate that the ATP hydrolysis of
Lon protease might be involved in unfolding of itssubstrates to
allow access tosites susceptible to peptide bond cleavage.Other
energy dependent proteases have been shown to possess chaperon-
likefunctions, however theseproteasesaremultimericproteins
made up of non-identical subunits and the ATPase domain and the14
catalyticdomainresideintwoseparatepolypeptidechains
(reviewed in 52).
Both invitro and invivostudies of Lon dependent protein
degradation have clearly demonstrated theability of Lon protease
todistinguish between substrateand non-substrateproteinsand
thefactthatsubstrate recognition resides exclusively within the
proteaseanditssubstratesanddoesnotrequireanyother
signalingfactor.Peptide bond cleavage, takes placeat multiple
siteswithinasubstrate molecule and the sequence requirements
for these cleavage reactions are fairly relaxed.
One common feature of allphysiological Lon substratesis
theirproposedinteractioninvivowith other proteinsinthe
formationofmultiproteincomplexes. Theprotein/protein
interaction domains of theseproteins might representsitesthat
allow recognition by Lon protease.For three substrates, CcdA, Su1A
and RcsA, overproduction of their partners, CcdB, FtsZ and RcsB
respectively, was shown to extend thehalf-life of these proteins
(59,109,124).In addition, non-proteolytical suppression of two
phenotypes resulting from a deletion of the ion gene in E.coli, was
suggestedtodependonthedisruptionofprotein/protein
interaction between the Lon substrates RcsA and Su1A with their
respective partners (25), indicating a common feature displayed by
these protein-protein interaction domains (25).On the other hand,
work by Huisman and coworkers and Markovitz and coworkers
seemstoindicatethatLonproteasemightpossessseveral
recognitionsites,discriminating substrates with high affinity from15
those with low affinity(19,136).Markovitz isolated mutants in
Lon protease which had lost the ability to recognize one substrate
butstilldegraded othersubstrates, however these mutants were
neverfullycharacterized(136).Trempy and coworkers have
recently isolated mutations in Ionwhich give rise to a Lon protease
capable of degrading Su1A and a temperature sensitive mutant X0
protein(X 0 to, whichispresumably recognized by Lonasan
abnormal protein, but no longer degrade RcsA.The mutations were
mapped to the N-terminal portion of Lon. (Ebel, W., Dierksen, K. P.
and Trempy,J.E., manuscript inprep).Gottesman, et al.(60)
suggested a role for molecular chaperons such as DnaJ in the Lon
dependent degradation of RcsA.However,the work presented
examinedinvivoturnoverratesof Lon substratessynthesized
frommulticopyplasmids. Underthesenon-physiological
conditions, RcsA is believed to aggregate into insoluble complexes
inaccessible to Lon protease.No requirement for DnaJ or any other
chaperone has been demonstrated for the degradation of any of the
specific Lon substrates under physiological conditions (60).In Ion
mutant cells, Lon substratesarestilldegraded,albeitat much
slower rates (14,109).Several activities have been implicated in
this Lon independent degradation of Lon substrates(14,63,117,
118) and the requirement for DnaJ in the degradation of high levels
of RcsA might indicate a requirement of one of these alternative
proteases for the molecular chaperone.
The findings discussed above stillleave one major question
unanswered. How dotheproteaseanditssubstratesinteract?16
What features of the substrate allow specificinteraction with the
protease and discriminate substrates from non-substrates?
Lon Protease In E. coli And Other Organisms
Energy dependent proteolysisisa process employed byall
living organisms.Several of the major proteases involved in this
process are highly conserved from species to species (51).ion
genes have been identifiedin numerous eubacterialspecies,the
archaeonMethanococcusjannaschiiandtheeukaryotes
Saccharomyces cerevisiaeand Homo sapiens.The overall structure
of the protease, judged from alignmentsof the primary amino acid
sequence, is well conserved between all these isolates.The highest
degree of conservation is found in theregions defining the ATP
binding domain and thecatalyticallyactiveserine residue(51),
however, the function and (putative) substrates(where known, see
below) vary greatly from organismto organism.Table1listsall
organisms in which Lon protease has beenidentified,its (probable)
function and substrate(s) where known.
Putative ion genes from Haemophilusinfluenzae, Mycoplasma
genitalium, Mycoplasma pneumoniae,Methanococcus jannaschii,
the nematode Caenorhabditis elegans,Schizosaccharomyces pombe
and Zea mays (13, 27, 28, 53, 134) havebeen identified basedon
sequence information obtained as part of wholegenome sequencing
projects carried out in these organisms;no information about the
function of the gene productsor the substrates of the protease is17
available to this date (see Table1for Gen Bank accession numbers
forsequencesthathave not been published).The Borrelia
burgdorferiliongenehasbeensequencedbutnofurther
information on thegene product orsubstratesisavailable(see
Table1for Gen Bank accession number).
The ion genes from Bacillusbrevis, Caulobactercrescentus,
Homo sapiens and Saccharomycescerevisiae, as well as the lonV
gene from Myxococcusxanthus were isolated based ontheir
sequence similarity to other, previously identified, Ion genes, using
Southern blot or PCR techniques.
In B.brevis, a mutation in the iongene does not result in any
obvious phenotype and the Lon protease in this organism does not
appear to be involved inthe heat shock response.No specific
substrate has been identified for the B. brevis Lon protease, and B.
brevision mutants are impaired inthe degradation of abnormal
proteins(57).The presence of a heat shock inducible, Lon-like
protein in Caulobactercrescentuswasfirstdemonstratedby
Reuter, et al.using antiserum raisedagainsttheE.coliLon
protease (86).Synthesis of this Lon-like protein was demonstrated
toincrease under heat shock conditions and tobe preferentially
synthesized in the stalked cell during the developmental cycle of
C. crescentus.The actual Ion gene in this organism was not isolated
until recently (135).
The presence of a heat shock inducible, Lon-like protein in
Caulobacter crescentuswas first demonstrated by Reuter, et al.
using antiserum raised against the E. coliLon protease (86).Table1.Lon protease in pro- and eukaryotes
Organism Gene Name Function Putative Substrate Reference
prokaryotes
Azospirillumbrasilense ion heat shock
iron uptake
Bacillus brevis ion deg. of abnormal
proteins
Bacillus subtilis ion sporulationcontrol
heat shock
Borrelia burgdorferei lonb ?
Caulobacter cresentus ion swarmer cell develop.
heat shock
Erwinia amylovora ion SOS pathway
capsule gene expression
heat shock
?
?
(78)
abnormal proteins(57)
cYG (?)
?
?
(87,94)
CcrM (DNA methylase)
?
?
(86,
(24)
135)
?
?
00Table 1.Lon protease in pro- and eukaryotes
Organism Gene Name Function
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?Table 1.continued
Salmonellatyphimurium Ion SOS pathway
capsule gene expression
deg. of abnormal proteins
Vibrio parahaemolyticuslonS swarmer celldifferentiation
eukaryotes
Homo sapiens
Caenorhabditis
Saccharomyces
122)
elegans
cerevisiae
LON
LONa
LON
(PIM1)
7
7
9
9
9
7
mitochondrial homeostasis 13subunit of
Fl ATPase
P subunit of general
matrixpeptidase
(23)
(105)
OTable 1.continued
Schizosaccharomyces pombe LONa'c ? ?
Zea mays LON1" ? ?
LON2a'e ? ?
a Identified as
b unpublished,
C unpublished,
d unpublished,
e unpublished,
part of agenomesequencing project
sequencesubmittedtoGen BankAccs.#L77216
sequencesubmittedtoGen BankAccs.#Z54285
sequencesubmittedtoGen BankAccs.#U85494
sequencesubmittedtoGenBankAccs.#U85495
IN)22
Synthesis of thisLon-like protein was demonstratedtoincrease
under heat shock conditions and to be preferentially synthesized in
the stalked cell during the developmental cycle of C.crescentus.
The actual Ion gene in this organism was not isolated until recently
(135).CcrM, an adenine DNA methyltransferase,isthe putative
substrate of the C. crescentusLon protease.CcrM dependent DNA
methylation isa stringently regulated process inthis organism and
Ion mutants show several developmental defects such asloss of
precise initiation of DNA replication and incomplete cell division.
CcrM isstabilized in Ion mutant strains but no invitro data are
available.
The Bacillus subtilis Ion gene was isolated independently by
two groups.Riethdorf, et al. identified the gene in a screen for heat
inducible promoters(87)and Schmidt, et al.identified the same
genewhilecharacterizingmutationsresultingininappropriate
expressionof genescontrolled bythesporulationtranscription
factor aG (94).In ion mutant strains, transcription of genes under
the control of a G are expressed independently of the appropriate
sporulation signal.It appears that aG itself, rather than a regulator
of 0 G expression,isasubstratefor Lon dependent degradation,
since a G dependent gene expression isstimulated in Ionmutants
expressing aG from an IPTG inducible promoter (94).The evidence
for a G being a substrate for Lon dependent degradation is indirect
and awaits verification through in vitro turnover experiments.
The human LON gene was the first Ion gene isolated from a
eukaryote.Wang, et al.identifieda clone among alibrary of23
expressed sequence tags derived from random human cDNAs which
showed a high degree of homology to the E.coli Ion gene (128).
This sequence information was used to clone the human LONgene.
Human Lon protease is a nuclear encoded protein of 106 kDa with a
mitochondrialmatrixtargetingsequenceattheN-terminus,
accountingforthelargersize when comparedtotheE.coli
protease.Immunofluoresence microscopy as well as in vitro and in
vivomitochondrial import assays demonstratedthat human Lon
proteaseisindeed imported into mitochondria where the mature
form of the protein is generated.Expression of the LON gene was
observedinall human tissues examined with the highest levels
seeninbrain,heart,liverandskeletalmuscletissue.No
information on the function or thesubstrates of the proteasein
humans is available.The human enzyme expressed in E. coli does
not complement ion mutations in E.coli (51) and Wang, et al.
reportedthat human Lon proteaseexpressedinE.coliisnot
inhibited by the T4 encoded Lon specific protease inhibitor PinA.
(128,129).
The Saccharomycescerevisiae Lonwasindependently
isolated by two groups.Suzuki et al. set out to clone the yeast LON
gene, which was biochemically identified by Goldberg,et al. and
Kutejeva, et al. (39, 66), using a PCR approach (110).Van Dyck, et
al.identified the sequence of a nuclear encoded ATP dependent
protease, called Piml by these investigators, which istargeted to
the mitochondria, among the sequences generated by the European
Community project to sequence chromosome IIof S.cerevisiae.24
The LON (PIM]) gene product showsahighsimilaritywith
bacterial Lon proteases, especially over the ATP binding domain
and theserineactivesite(60%). LON mutantsareunableto
maintain an intact mitochondrial genome, resulting inthe inability
toutilize non-fermentable substratesassole carbon source (110,
122).S.cerevisiae mutant for Lon protease were shown tolack
mitochondrial ATP dependent proteolytical activity and accumulate
inclusion bodies inthe mitochondrial matrix.Two proteinsare
stabilizedinthesecells,the(3subunitofthegeneralmatrix
peptidase and the Fl ATPase 13subunit (110).Piml was shown to
be a heat shock protein whose synthesis is increased approximately
4foldafterheatshock.Teichmann, et al.demonstrateda
functional conservation between the E. coli Lon protease and the S.
cerevisiae Lon protease (113).A chimeric protein, consisting of the
E. coli Lon protease fused with a mitochondrial targeting signal, was
showntobeimportedintomitochondria andexhibitprotease
function against abnormal proteins.S.cerevisiae LON mutants
expressingthischimericproteinpreservetheintegrityofthe
mitochondrial genome and are respiration competentat 300C but
not at 370C.Suppression of the LONphenotypes is not complete
and degradation of the putative S.cerevisiae Lon substrates by the
chimeric protein has not been demonstrated in vivo or invitro.In
contrasttotheE.colienzyme,theyeast enzyme appearsto
assemble as a hexamer (67).
As in B.subtilis, the lon gene from Azospirillumbrasilense,
lonD in Myxococcus xanthus and lonS in Vibrioparahaemolyticus25
wereidentifiedingeneticscreensnotspecificallydesignedto
identify Ion or other protease genes.
The A.brasilenseLon protease was identified as part of a
screen attemptingtoisolate genes involved iniron uptake. A.
brasilense Ion mutants are defective in their ability to take up iron
from their environment and thedefect has been linkedtoiron
transport rather then to the ability to produce siderophores such as
catechol (78).Although a substrate has not been identified, at least
two membrane proteinsinduced byironstarvationcannotbe
detected in Ion mutants of A.brasilense.The absence of these
proteins in ion mutant strainsindicatesa rolefor Lon protease,
eitherdirectlyorindirectly,inregulatingthestabilityorthe
expression of these proteins.
Myxococcus xanthusis the only organism so far in which two
Ion genes have been cloned and sequenced.However, based on
Western blot results, using antiserum raised against the E. coliLon
protease, Dierksen, et al. hypothesized the presence of multiple Lon
proteasesinB.subtilis, Lactococcuslactisand Pseudomonas
aeruginosa(21).Inadditiontotheseorganisms,aprotein
immunoreactiveto Lon antiserum was identified from Proteus
vulgaris, Vibrio anginolyticus, Xanthomonas campestris, Alcaligenes
viscolactis, Rhizobium sp.,Agrobacteriumradiobacter,Bacillus
stearothermophilus and Streptococcussalivarius (21).Sequences
for two Zea mays LON genes (LON1 and LON2) have been identified
but no information on their function is available (see Table 1).26
Tojo, et al.identified both ion genesandsuggestedthe
nomenclature lonD for the gene involved in development and Ion V
forthegenerequiredforvegetativegrowth(114,115).
Independently from Tojoet al.,Gill, et al.(35) determined the
nucleotidesequence ofapreviouslyidentifiedgene, bsgA, and
found it to encode a protein with a high degree of homology (60%)
to the E. coli Lon protease.The purified protein possessed ATP
dependent proteolytic activity against methylated casein (35).
M. xanthuslonD (bsgA) mutants are blocked in an early stage of
developmentanddonotformfruitingbodiesorspores.
Interestingly,these mutants can be rescuedifco-culturedwith
wild-typecells,indicatingthatLonproteaseisinvolvedin
generatingarequiredcell-cellsignalneededtocompletethe
developmentalcycle(34).Both groupsshowedthatIonis
expressed during vegetative growth as well as during development
of M. xanthus.
Tojo, et al. reported the identification of a second Ion gene in
M. xanthus.In contrast to all other organisms where Lon protease
is non essential under normal growth conditions, the gene product
of the lonV gene, was shown to be essential for vegetative growth
of this organism, since no viable null mutant could be isolated.The
gene was identified using a Southern blot approach with the C-
terminal half of the E. coli Ion gene as a probe.The lonV gene is
constitutively expressed throughoutthe M. xanthus cell cycle as
judged from data obtained from lonV::lacZ fusion experiments.The
lonV mutant was also shown to complement thenitrofuranotin-27
sensitive phenotype of E.coli Ion mutants (114).The LonD and
LonV proteases of M. xanthushave to differ in their substrate
specificity, since a lonD mutant is viable.The primary amino acid
sequence of these two proteins shares a high degree of similarity
over the C-terminal region of the protein but varies greatlyat the
N-terminus, suggesting a role of this region in substrate binding.
The V. parahaemolyticus lonS gene was identified in a search
forgenes involvedinregulatingtheconstitutiveexpressionof
lateralflagellar(laf) genes (105).The lateral flagellar genes are
part of a multi gene regulon normally expressed only when cells
colonize a surface and develop into swarmer cells.Free swimming
V.parahaemolyticus lonS mutants express laf genesconstitutively
inthe absence of the environmental signal required for induction
in wild-type cells and show an elongated cell morphology usually
observed with swarmer cells grown on plates.Expression of the V.
parahaemolyticuslonS gene in E. coli Ion mutants was shown to
complement at least two phenotypes resulting from a Ion mutation
in E. coli: overexpression of capsular polysaccharide and sensitivity
to DNA damaging agents.This observation appears to indicate that
thefunctionof Lon protease between thesetwo organismsis
conserved(105).However,thecomplementationofthe/ o n
phenotypes in E.coli by the LonS gene product is solely based on
phenotypicobservationsandothergeneproductshavebeen
isolated which are capable to complement E. coli lon phenotypes in
anon-proteolyticmanner(25). Toprovethefunctional28
conservationoftheLonproteasesofthesetwoorganisms,
degradation of Lon substrates would have to be demonstrated.
Mutations in the ion gene of Salmonellatyphimurium were
identified making use of the observation that E. coli Ionmutants
arelesssensitive to phenotiazines as compared to wild-type cells
(77).S.typhimurium Ion mutants are mucoid and sensitive to DNA
damaging agents.The S.typhimurium Lon protease was shown to
complementE.coli Ion phenotypes.The partially purified Lon
protease was shown topossess ATP dependent proteaseactivity
(23).
So far, the Erwinia amylovora Iongene is the only lion gene
identified by usingacomplementation approach(24).Several
other ion genes were shown to phenotypically complement E.coli
ion mutants, but this observation was not used to isolate Iongenes
from any organism other than E.amylovora.Several reasons may
account for the fact that a complementation approach might not be
successful:high levels of Lon protease in E.coli are toxic to the
cells and therefore lon genes on multicopy plasmidsare frequently
inactivated by insertion elements disrupting the Ion ORF (37); the
capsule phenotype most often used in complementation approaches
has been shown to be complemented innon proteolytic fashion by
aseveralheterologousgene products(25)notrelatedtoLon
protease.Both these factors might contribute to the fact that only
one Ion gene, from a closely related species, was identified based
on theabilityto functionally complement E. coli ionmutants.E.
amylovora Ion mutants are mucoid and sensitive to DNA damaging29
agents and Lon expression was shown to be increased under heat
shock conditions (24).
As mentioned before, the lon gene from E.coli was the first
Ion gene to be identified.Lon protease from E.coli is the best
studied of the energy dependent proteases and almostallof the
mechanisticinformation ontheproteolytic mechanism andthe
proteasesubstrateinteractions come frominvitro and invivo
studies of the E.coli enzyme.Invivodegradationofspecific
substratesinanenergydependentfashionhasonlybeen
demonstrated for three of the four known, specific substrates, Su1A,
CcdA and XN protein of the E. coli Lon protease (71, 104, 124) and
hasnot been demonstrated for any of theother Lon proteases
identified to date.
E. coli Lon Protease And ItsSubstrates
RcsA, Regulator Of Capsule Synthesis
E. coli Ion mutants exhibit several well defined phenotypes,
explained by the stabilization of several regulatory proteins.The
most obvious and visible phenotype of E. coli lon mutants is the
overproduction of the exopolysaccharide colanic acid.Expression of
thestructural genes involved inthesynthesis of colanic acidis
stringentlyregulatedbyacomplicated network ofregulators,30
ensuringthiscapsuleisonly expressedundertheappropriate
conditions (see below).Lon protease plays a key role in regulating
capsule gene expression by degrading RcsA, a positive regulator of
capsule gene expression, thus limiting its availability.lon+ cells are
non mucoid and RcsA israpidly degraded ina Lon dependent
fashion, with a half-life of approximately1min. (109).In Alon
cells RcsA isstabilized(half-life 30 min.) and abletoactivate
capsule gene expression leading to mucoid cells (109).
Su1A, Inhibitor Of Cell Division
A second phenotype associated with a mutation in Ion is the
sensitivity of thesecellsto UV light and other DNA damaging
agents.After exposure to DNA damaging agents Mon cells form
long,non resolvingfilamentsandeventuallydie(54).This
sensitivitytoDNA damagingagentsandtheassociated
filamentation could be suppressed by several second site mutations
and was shown tobe dependent on the induction of the SOS
regulon(30).Eventually SuIA wasidentifiedasthecentral
regulator involved in the filamentation, and as a substrate for Lon
dependent degradation (47, 76).Degradation of Su1A was shown to
be energy dependent, Su1A persists in lon+ cells if intracellular ATP
pools are depleted through the addition of KCN (117).Su1A is a cell
division inhibitor which interacts with FtsZ, an important member
of the cell division machinery of E. coli (68, 69).The sulA gene was
shown to be a part of the SOS regulon (75).All members of the SOS31
regulon are regulated inasimilar fashion: under normal growth
conditions their expression is down regulated due to the binding of
the LexA repressortoconserved operatorsitesinthe promoter
regions of these genes and operons.In response to DNA damage,
RecA proteinisactivatedto catalyze theself cleavage of LexA
repressor.Thisinactivationof LexA leadstoanincreased
expression of the members of the SOS regulon (for a general review
of the SOS system see 127).
During normal growth of E. coli lon+ cells sulAexpressionis
low andallsynthesized Su1Aisdegraded ina Lon dependent
fashion with a half-life of less than 2 min.Su1A iseffectively
cleared from the cell thereby preventing its interaction with FtsZ to
block cell division (76). Upon induction of the SOS response, sulA
expression is increased and Su1A levels in the cell increase to levels
saturating Lon protease, thus leading to the accumulation of Su1A
(56).Under these conditions Su1A, the only member of the SOS
regulon needed to arrest cell division (56), can interact with FtsZ to
block cell division.Repair of the DNA damage removes the signal
for RecA activation and, consequently, LexA isstabilized, allowing
itto bind toitstargetsitestoshut off expression of the SOS
regulon.As SulA synthesis ceases, Lon protease can "catch up" and
completely degrade the accumulated Su1A protein.Once Su1A is
cleared,celldivisioncan resume,andthetransientlyformed
filaments resolve.This mechanism allows for repair of damaged
DNA before chromosomes are segregated and cells divide (76).32
In %lon cells the accumulated Su1A cannot be degraded even
after the SOS response is shut off and cells form long, non-septated
filaments and ultimately die (76).
Lon dependent degradation of SulA, as well asthe energy
requirement forthisdegradation,has been demonstratedinvivo
and invitro(104,117) and interaction of Su1A with FtsZ was
demonstrated by severalinvestigators(7,8,18,55,59).This
interactionwas showntoprotectSulA from Lon dependent
degradation (59).Overproduction of Su1A protein was shown to
saturate Lon protease as judged by the mucoid phenotype seen in
cells overexpressing SulA in the presence of Lon protease (19)
XN Protein
The first protein to be identified as a Lon substrate was XN
protein (46).Gottesman, et al. demonstratedthe role of Lon in the
rapiddegradationoftheantiterminatorX N.A defect in the
degradation of XN protein can account for the poor lysogenization of
lon-cellsandtherapid commitment of lysogenstothelytic
pathwayafterheat induction(46).Maurizi used purified X N
proteintodemonstrateforthefirsttime Lon proteaseactivity
against a specific substrate (71).In his experiments he proved that
the interaction of Lon protease with its substrates isspecific, since
otherproteinsincubatedwithpurified Lon proteasewerenot
degraded.The proteolytic fragments identifiedinthesestudies33
demonstrated that Lon protease cleaves substratesat multiple sites
and that the cleavage sites recognized by the protease do not share
a high degree of similarity.
CcdA, Control Of Cell Death Protein
The most recently identified, specific E. coli Lon substrateis
CcdA (control of c ell death),theantidoteof apoison/antidote
plasmid addiction system encoded by the F plasmid (123).Plasmid
addictionsystems(also known aspost segregationkilling)are
designed to ensurestable inheritance of many low copy number
plasmids and generally consist of astable toxin and an unstable
antidote encoded by the plasmid.In cells harboring the plasmid,
bothtoxinandantidotearecontinuouslysynthesizedandthe
antidote interacts with the toxin to neutralize its activity.The toxin
molecules arestable, while the antidote molecules are subject to
proteolyticdegradation.If,aftercelldivisionacelldoes not
containacopyoftheplasmid,theantidotemoleculesare
eventually degraded, allowing thestable,persistent,toxintokill
the cell (reviewed in 58).CcdA was shown to be stabilized in Alon
cellsin vivo (123) and invitroexperimentsdemonstratedLon
dependent degradation of CcdA and the ability of CcdB to protect
CcdA from Lon dependent degradation (124).As seen with XN
protein, Lon cleaves CcdA atmultiplesites and the amino acid34
sequences of thesesites do not share any significant amount of
similarity to account for Lon's specificity (124).
Abnormal Proteins And Proteins Without Partners
Lon's function isnot limited tothe degradation of specific
regulatory or "timing" proteins.As a member of the heat shock
regulon Lon's synthesis is up regulated during heat shock (36, 82).
Increasedlevelsof Lon ensurethatabnormal, nonfunctional
proteins are degraded and cleared from the cell(3,12,38).In
addition, Lon protease has been shown to degrade specific protein
componentsofmultisubunitproteincomplexesthatare
synthesized at abnormal levels (10, 81).
Regulation Of Capsule Gene Expression In E. coli
Capsule gene (cps) expression in E.coliis governed by a
complex network of regulators (Figure 2).At least two pathways
have been identified which canleadtotheactivationof cps
expression.Thefirst pathwayishypothesizedtotransmitan
environmentalstimulus,suchasdesiccationorosmoticshock,
throughaproposedtwocomponentsensor/regulatorpairto
activatecps expression.The first pathwayishypothesizedto
transmit an environmental stimulus, suchas desiccation or osmotic
shock, through a proposed two component sensor/regulator pairto35
activate cps expression.Based on sequence homology toother
sensor/regulatorpairs,RcsC,a104 kDa membrane proteinis
hypothesized to be the sensor component of thesensor/regulator
pair with RcsB being the cognate regulator (108).Recently Trempy
andcoworkershaveidentifiedamutationin mdoHwhich
increases cps expression.The product of the osmoregulated mdoH
geneisa membrane bound protein involved in the synthesis of
membrane derived oligosaccharides (MDOs).The change in levels
of MDOs,inresponsetochangesintheosmolarityofthe
environment, might represent thesignal which RcsC senses and
relays to RcsB (Ebel, W. Vaughn, G. J., Peters, H., K., III and J. E.
Trempy, submitted).Itisunclear whether RcsC functionsasa
phosphatasetoremoveaphosphategroupfromactivated,
phosphorylated RcsB or as a kinase to phosphorylate non-activated
RcsB (45,107).An additional activity, RcsF, has been identified
whichappears,eitherdirectlyorindirectly,toactivatec p s
expression through activation of RcsB (31).RcsB, the effector of the
twocomponentsensor/regulatorpair,isessentialforc p s
expression.cps expression in rcsB-strains is low and cannot be
activated by overexpression of any other positive regulator of cps
expression. RcsBshowssimilaritytootherregulatorsof
sensor/regulatorpairs(108)andsitedirectedmutagenesis
identifiedtheconserved Asp-56astheresidue most likelyto
receive the phosphate group, since an Asp 56 to Asn mutant has
lost activity (45).Periplasm
Cytoplasm
env. stimulus capsule
RcsB
RcsA
rcsA
Figure 2.Model of capsule gene regulation
Modified from V. Stout (1994),Res. Microbiol. 145:389-392.37
RcsB has a C-terminally encoded helix-turn-helix motif suggesting
its function as a transcriptional activator of cps expression (109).
For maximal expression of the cpsoperon, activated RcsB needs to
interact with a second positive activator of cps expression,RcsA.
RcsA isa short lived protein with a half-life of approximately1
min. (109).RcsA is degraded in a Lon dependent fashion invivo
and cps expression is low in lon+ cells(109).Constitutively
activated RcsB, or RcsB expressed from a multicopy plasmid (11),
can overcome the absence of RcsA in lon+cells, however cps
expression is maximal in Alon cells, since RcsA is stabilized and able
to realize its biological function (109).
Thesecondpathwayleadingtotheactivationof cps
expression is dependent on RcsA.As mentioned earlier, RcsA is
degradedinLondependentfashionwithahalf-lifeof
approximately one minute (109). In lon+ cells RcsA is the limiting
factor for the activation of cps expression and stabilization of RcsA
in A Ion cells or overproduction of RcsA from a multicopy plasmid in
lon+ cells leads to high level expression of the cps operon (109).
The activation of cps expression isabsolutely dependent on RcsB
and rcsB- cellsare non-mucoid (11), independent of the presence
of RcsA, suggesting an auxiliary role of RcsA in cps expression (11,
116).The primary amino acidsequenceof RcsA containsa
putative helix-turn-helix motif which has been hypothesized to be
the DNA bindingsiteof RcsA,however,noinvitrodata
demonstrating RcsA bindingtothe cps promoter regionexists
(109).Recently, Sledjeski et al. have identified H-NS, a histone-like38
protein,asa negative regulator of rcsA expression, as well as a
small,stable RNA, the product of the dsrAgene, which can
overcome H-NS silencing when expressed in multicopy (100).In
the absence of H-NS, lon+cells are mucoid, suggesting that the
regulation of rcsA expression might representa mechanism for
cells to regulate cps expression in response to intracellular signals,
allowing a cell to increase capsule gene expression either as a result
of environmental changes through activation of RcsB, or through an
increase in RcsA content by increasing rcsA expression.Beyond the
silencing of rcsA expression by H-NS and the multicopy effect of
DsrA on H-NS,littleisknown about theregulationof rcsA
expression.No consensus heat shock promoter or "SOS box" can be
found inthe rcsA promoter regionanditappearsthat rcsA
expression is not up-regulated in response to osmotic shock (G.J.
Vaughn, personal communication) and rcsA expression is believed
to be constitutive.
Lonproteasehasbeenidentifiedasoneofthemost
important energy dependent proteases in E.coli.Lon protease has
been identified in a large number of pro- and eukaryotes and its
structureiswell conserved among allisolates.Despite intensive
investigations,littleis known about the mechanism of substrate
recognition of any of the known Lon proteases.In vitrowork with
specificsubstratesandnon-substratesandcomplementation
studies suggest that a Lon protease is:a) capable of distinguishing39
betweensubstrateandnon-substrateproteins;b)substrate
recognition is accomplished by Lon protease and/or itssubstrates
withouttheneedforanyadditionalfunction andc)substrate
characteristicsand recognitionareconserved,atleastpartially,
between isolates from different species.
ResearchObjectives
The objectives for the studies presented here were to identify
mutant Lon substrates which were no longer degraded ina Lon
dependent fashion and touse the information obtained from the
mutantstogenerateamodelforthemechanism ofsubstrate
recognition of theE. coli Lon protease.Furthermore,abetter
understanding of theinteraction of Lon and RcsA might provide
furtherinformationonthemechanismsgoverningcpsgene
expression.Materials And Methods
Reagents
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All chemicals were purchased from Sigma (St.Louis, MO)
unless otherwise noted.Restriction enzymes and T4 DNA ligase
were purchased from New England Biolabs (Beverly, MA), Taq DNA
polymerase was purchased form Promega (Madison, WI), dNTP mix
was purchased from Stratagene.Ingredientsfor growth media
were manufactured by Difco (Detroit, MI).
Strains, Media And Growth Conditions
Strains, plasmids and phages used in this study are listed in
Table 1.Cells were grown in LB broth (10 g Tryptone, 5g Yeast
extract, 5 g NaC1/1, pH 7.4) (91) at 370C containing the appropriate
antibiotics(ampicillinat100la g/ml, kanamycinat25 lig/ml,
tetracyclin at 25 µg /ml and chloramphenicol at 25 1.1g/m1)unless
otherwisenoted.Table 2.Bacterial strains, plasmids and phages used in this study.
Straina, Plasmid
or Bacteriophage
Relevant genotype Construction, Source or
Reference
Bacterialstrains
CAG18451
DH5ab
DDS90
DDS1398
JT2029
JT2046
JT2055
JT2056
JT2057
zed-3069::Tn1 0
F- endA1hsdR17 (rk-mk+) supE44thi-1 recA1
gyrArelA1A(lacZYA-argF)(1169(080dlacA(lacZ)M1 5)
Ion+ rcsA+ rcsB+ rcsA90::lacZ
hns::AKan
F-Alac araD proCYA22 1
zaj-403::ATn1 0 rcsA90::lacZ
Alon rcsA+rcsB+rcsA90::lacZ
Alon rcsA-rcsB+rcsA90::lacZ
Alon rcsA+rcsB-rcsA90::lacZ
Ion+ rcsil-rcsB+ rcsA90::lacZ
(98)
Gibco/BRL
D. Sledjeski; (81)
D. Sledjeski; (100)
DDS90 + P1 (SG1030)
JT2029 + P1 (SG4144)
JT2046 + P1 (SG23001)
JT2046 + P1 (SG23002)
DDS90 + P1 (SG23001)
.4Table 2. continued
JT2058 lon+rcsA+rcsB-rcsA90::lacZ DDS9O + P1 (SG23002)
JT2059 Alon rcsA-rcsB-rcsA90::lacZ JT2056 + P1 (SG20806)
JT2060 Ion+ rcsA-rcsB-rcsA90::lacZ JT2058 + P1 (SG20806)
JT2181 Ion+ sulA::lacZ SG20250 + X(sfiA::lacZ)
JT2182 Alon sulA::lacZ JT4001 + X(sfiA::lacZ)
JT4000 Alon-510 SG1O3O + P1 (SG4144)
JT4001 Alon -510Agal JT4000 + P1 (SA2692)
SG1O3O F-Alac araD proCYA221zaj -403::ATn10 (119)
SG4144c N99 Alon -510 (73)
SG20250 Ion+ Alac (49)
SG20250-ki434 thisstudy
SG20322 1on146::ATn10 (73)
SG20581 Ion- -100 (119)
SG20780 Alon-510 cpsBio::lacZ (11)
SG20781 lon +cpsBjo::lacZ (11)
SG20806 Alon-510 rcsC137 ompC::Tn5 rcsA72::ATn10 (11)Table 2.continued
SG21081
SG23001
SG23002
WE8
WE10
WE12
WE14
WE15
WE16
WE17
WE18
WE19
WE20
WE21
WE22
Ion+ cps+ rcsA72::ATn10
rcsA::Akan (rcsA-)
rcsB62::Akan (rcsB-)
lon::ATn10 rcsA90::lacZ
hns::AKan rcsA90::lacZ
lon::ATn10 hns::4Kan rcsA90::lacZ
lon+rcsA::ATn10 cps1310::lacZ
Alon-510 rcsA::ATn10 cpsBjo::lacZ
Ion+ rcsA::ATn10
Alon-510 rcsA::Tn10
dlon-510 rcsA+zed-3069::ATn10 cpsBjo::lacZ
Ion+ rcsA+zed-3069::ATn10 cps1310::lacZ
lon+ rcsA+zed-3069::4Tn10
Alon-510 rcsA+zed-3069::ATn10
dlon-510 rcsA+ zed-3069::ATn1 0
cpsBio::lacZrcsB::AKan
(11)
S. Gottesman
(109)
DDS90 + P1 (SG1117)
DDS90 + P1 (DDS1398)
WE8 + P1 (DDS1398)
SG20781 + P1 (SG21081)
SG20780 + P1 (SG21081)
SG20250 + P1 (SG21081)
JT4000 + P1 (SG21081)
SG20780 + PI (CAG18451)
SG20781 + PI (CAG18451)
SG20250 + PI (CAG18451)
JT4000 + P1 (CAG18451)
WE18 + P1 (SG23002)Table 2.continued
WE23
WE29
WE35
WE108
WE110
WE112
WE113
WE114
WE125
WE208
WE210
WE212
WE213
WE214
WE225
Ion+ rcsA+zed-3069::ATn10
cpsBio::lacZrcsB::AKan
lon::Alcan
lon+ rcsA+ zed-3069::ATn10 rcsA90::lacZ
Ion+ rcsA *108 cps1310::lacZ
Ion+ rcsA*110 cps1310::lacZ
Ion+ rcsA *112 cpsB1 0::lacZ
Ion+ rcsA *113 cps1310::lacZ
Ion+ rcsA*114 cpsB 10::lacZ
Ion+ rcsA*125 cps1310::lacZ
zed-3069:: ATn10
zed-3069::ATn10
zed-3069:: ATn10
zed-3069:: ATn10
zed-3069::ATn10
zed-3069:: ATn10
Ion+ rcsA *1°8 zed-3069::ATn10
Ion+ rcsA*110 zed-3069::ATn10
Ion+ rcsA *112 zed- 3069::ATn10
lon+ rcsA *113 zed-3069::ATn10
lon+ rcsA *114 zed-3069::ATn10
Ion+ rcsA *125 zed-3069::ATn10
WE19 + P1 (SG23002)
thisstudy
DDS90 + P1 (CAG18451)
this
this
this
this
this
this
study
study
study
study
study
study
SG20250 + P1 (WE108)
SG20250 + P1 (WE110)
SG20250 + P1 (WE112)
SG20250 + PI (WE113)
SG20250 + PI (WE114)
SG20250 + P1 (WE125)Table 2.continued
WE308
WE310
WE312
WE313
WE314
WE325
WE408
WE410
WE412
WE413
WE414
WE425
WE508
WE510
WE512
ion+ rcsA *108 cps1310::lacZ rcsB::AKan
Ion+ rcsA*110 cpsB 10::lacZ rcsB::AKan
ion+ rcsA *112 cps1310::lacZ rcsB::AKan
ion+ rcsA *113 cps1310::lacZ rcsB::AKan
ion+ rcsA *114 cpsBjo::lacZ rcsB::AKan
Ion+ rcsA *125 cps131,9::lacZ rcsB::AKan
ion+ rcsA*108 zed-3069::AT n10
lon+ rcsA*110 zed-3069::ATn10
lon+ rcsA *112 zed-3069::ATn10
lon+ rcsA*113 zed-3069::ATn10
Ion+ rcsA *114 zed-3069::4Tn10
ion+ rcsA *125 zed-3069::ATn10
ion+ rcsA*108 rcsA90::lacZ
Ion+ rcsA*110 rcsA90::lacZ
lon+ rcsA*112 rcsA90::lacZ
WE108 +
WE110 +
WE112 +
WE113 +
WE114 +
WE125 +
SG20250
SG20250
SG20250
SG20250
SG20250
SG20250
DDS90 +
DDS90 +
DDS90 +
P1 (SG23002)
P1 (SG23002)
PI (SG23002)
P1 (SG23002)
P1 (SG23002)
PI (SG23002)
+ P1 (WE108)
+ P1 (WE110)
+ P1 (WE112)
+ P1 (WE113)
+ P1 (WE114)
+ P1 (WE125)
P1 (WE108)
P1 (WE110)
P1 (WE112)Table 2.continiued
WE513
WE514
WE525
WE608
WE610
WE612
WE613
WE614
WE625
WE1002
WE1003
WE1004
WE1012
WE1013
WE1014
Ion+ rcsA*113 rcsA90::lacZ
lon+ rcsA*114 rcsA90::lacZ
Ion+ rcsA*125 rcsA90::lacZ
lon::AKan rcsA*108 rcsA90::lacZ
lon::AKan rcsA*110 rcsA90::lacZ
lon::AKan rcsA*112 rcsA90::lacZ
lon::AKan rcsA *113 rcsA90::lacZ
lon::AKan rcsA*114 rcsA90::lacZ
lon::AKan rcsA*125 rcsA90::lacZ
lon+ rcsA+ rcsA109::lacZ
lon+ rcsA+ cpsiO3::lacZ
lon+ rcsA+ cps41::lacZ
Ion+ proCYA221zaj-403::ATn10 rcsA109::lacZ
lon+proCYA221zaj-403::ATn10 cps1o3::lacZ
Ion+ proCYA221zaj-403::ATn10 cpszti ::lacZ
DDS90 + P1 (WE113)
DDS90 + P1 (WE114)
DDS90 + P1 (WE125)
WE508 + P1 (WE29)
WE510 + P1 (WE29)
WE512 + P1 (WE29)
WE513 + P1 (WE29)
WE514 + P1 (WE29)
WE525 + P1 (WE29)
SG20250 + XRS45-rcsA109::/acZ
SG20250 + ARS45-cps103::1acZ
SG20250 + XRS45-cps41::lacZ
WE1002 + P1 (SG1030)
WE1003 + P1 (SG1030)
WE1004 + P1 (SG1030)Table 2.continued
WE1022 Alon-510 rcsA± rcsA109::lacZ
WE1023 Alon-510 rcsA+ cpsio3::lacZ
WE1024 Alon-510 rcsA+ cps41::lacZ
WE1032 lon+rcsA::ATn10 rcsA109::lacZ
WE1033 ion+ rcsA::ATn10 cps103::lacZ
WE1034 lon+rcsA::ATn10 cps41 ::lacZ
WE1042 Ion+ rcsB::AKan rcsA 1 09: :lacZ
WE1043 ion+ rcsB::AKan cps! 03 :: lacZ
WE1044 Ion+ rcsB ::AKan cps41::lacZ
WE1052 Alon-510 rcsA::ATn10 rcsA109::lacZ
WE1053 Alon-510 rcsA::ATn10 cps103::lacZ
WE1054 Alon-510 rcsA::ATn10 cps41::lacZ
WEI 062 Alon-510 rcsB::AKan rcsA109::lacZ
WE1063 Alon-510 rcsB::AKan cps103::lacZ
WE1064 Alon-510 rcsB::AKan cps41::lacZ
WE1072 ion+ rcsA::ATn10 rcsB::AKan rcsA109::lacZ
WE1012 + P1 (SG4144)
WE1013 + P1 (SG4144)
WE1014 + PI (SG4144)
WE1002 + P1 (SG21801)
WE1003 + P1 (SG21801)
WE1004 + P1 (SG21801)
WE1002 + P1 (SG23002)
WE1003 + P1 (SG23002)
WE1004 + P1 (SG23002)
WE1022 + P1 (SG21081)
WE1023 + P1 (SG21081)
WE1024 + P1 (SG21081)
WE1022 + P1 (SG23002)
WE1023 + P1 (SG23002)
WE1024 + P1 (SG23002)
WE1032 + PI (SG23002) -p.Table 2. continued
WE1073
WE1074
WE1082
WE1083
WE1084
Plasmids
pATC400
pUC18-rcsA
pRS415
pRS415-cpsBox
pRS415-cpsNoBox
pRS415-rcsANoBox
pACYC184-lon
lon+rcsA::ATn10 rcsB::AKan cps103::lacZ
lon+rcsA::ATn10 rcsB::AKan cps41::lacZ
Alon-510 rcsA::ATn10 rcsB::AKan rcsA109::lacZ
Alon-510 rcsA::ATn10 rcsB::AKan cps103::lacZ
Alon-510 rcsA::ATn10 rcsB::AKan cps41::lacZ
pBR322-rcsA
pUC18 + BamHI-SalI from pATC400
bla-T14-EcoRI-SmaI-BamHI-lacZ
pRS415 + 194 by cps promoter fragment
pRS415 + 132 by cps promoter fragment
pRS415 + 121 by rcsA promoter fragment
pACYC184 +
1.2 Kb PstlISphI Ion fragment from 2,148
WE1033 + P1 (SG23002)
WE1034 + P1 (SG23002)
WE1052 + P1 (SG23002)
WE1053 + P1 (SG23002)
WE1054 + P1 (SG23002)
(116)
thisstudy
(97)
thisstudy
thisstudy
thisstudy
thisstudyTable 2.continued
pACYC184- lon::AKanpACYC184 -lon + 1.5 Kb KanR casette from pUC-4K thisstudy
pUC-4K pUC18-KanR Pharmacia
Bacteriophages
XNK1098 cI857 Pam80 nin5 mini Tn/O tet Ptac -transposase ATCC, (133)
XNK1324 cI857 Pam80 nin5
mini Tn/O cam Ptac transposase-ATS (atslats2) ATCC, (64)
A1 4 8 lon+ (65)
XRS45 imm2lind+ bla '-lacZsc (97)
imm434 imm434 Nancy Trun
X imm434 imm434 Nancy Trun
a all strains are MC4100 derived (4lacU169 araD flbB rel )unless otherwise noted
b commercial strain
NIH isolate50
Several solid media were used in theses studies.LB agar (LB broth
+ 15 g/1 agar), M63 Glucose B 1agar (3 g KH2 P 0 4, 7 g K211 P 0 4,
2 g (NH4 )2S 04 + 15 g agarose in 990 ml water; after autoclaving 0.5
ml of a 0.1% FeSO4 solution, 0.245 ml of a 1 M MgSO4 solution, 10
ml of a 20% (w/v) glucose solution and1 ml of a 1% Vitamin B1
solution were added prior to pouring the plates) or MacConkey's
Lactose agar (40gof MacConkey's agar base/1plus10gof
Lactose/1 added after autoclaving).Solid media was supplemented
withtheappropriateantibioticsafterautoclavingwhenever
needed.To teststrainsfortheirsensitivityto DNA damaging
agents,LBagarwassupplementedwith0.5m1/1methyl
methanesulfonate(MMS)(Aldrich,Milwaukee,WI)after
autoclaving or with 50 p.1 of Mitomycin C solution (2 mg/ml water)
spread per plate of pre-poured LB agar plates(thisresultsina
final conc. of approximately 2.51.1 g/m1).To test the sensitivity of
strains to UV light, 100 p 1 of a cell suspension of the strain to be
tested was spread on a LB plate and individual segments of the
plate were exposed to UV light on a UV transilluminator (TM20;
UVP, San Gabriel, CA) for 0, 15, 30, 45 or 60 seconds.For all three
tests,theability of astrainto grow inthe presence (MMS or
Mitomycin C) or after the exposure to (UV light) the DNA damaging
agent was assessed as the ability to form colonies on the particular
growth medium used.51
Nucleic Acid Extractions
Total Chromosomal DNA
Total chromosomal DNA from overnight cultures was isolated
following the procedure of Pitcher and Saunders (83) In brief, 5 ml
cultures were grown overnight, centrifugedat 5000 rpm and the
cell pellet resuspended in 100 ill TE (50 mM Tris, pH 8.0,1 mM
EDTA).The cellsuspension was transferredtomicrocentrifuge
tubes and incubated for 10 min. at 370C.Five hundred 1.11 of GES
reagent(0.5 mM guanidiumthiocyanate,100 mM EDTA and
0.5% v/v sarkosyl) was added and the mixture was gently inverted
for approximately 5 min.Following the addition of 250 IA of 7.5 M
ammonium acetate, the samples were incubated on ice for 10 min.
Five hundred1.11of chloroform/isoamyl alcohol (24:1) was added
and thesamples were mixed by gently invertingthetubesfor
approximately 5 min.After15 min. centrifugationat maximum
speed in a microcentrifuge (approximately 13000 rpm) to separate
the aqueous from the organic phase, the aqueous (top) phasewas
carefully removed toa fresh microcentrifuge tube.Four hundred
sixty g 1of ice cold isopropanol was added and the solutionwas
inverted gently for several minutes.The DNA was collected by
brief (1min) centrifugation, washed with 500 gl of 70% ethanol
(EtOH), dried under vacuum and resuspended in100p.1double
distilled,sterile(dds)water.The concentrationof DNA was
determinedbyspec troph otometryusingaShimadsu UV 160U52
spectrophotometer, where1O.D. unitat 260 nm isequaltoa
concentration of 50 lig of DNA/ml of solution.
SmallScalePlasmid Preparation
The protocol used to isolate plasmid DNA from 5 ml cultures
isdescribed in Sambrook, et al.(91).In brief, cells were grown
overnight, pelleted and resuspended in 100 p.1lysis buffer (50 mM
glucose, 25 mM Tris, pH 8.0 and 10 mM EDTA).After 10 min.
incubation on ice, 200 0 SDS/NaOH solution (0.2 N NaOH, 1% SDS)
wasadded,themixturecarefullyinvertedseveraltimesand
incubated on ice for another 10 min.To precipitate chromosomal
DNA and cellular debris,150 0 of 5 M potassium acetate was
added and the mixture was incubated on icefor an additional
10 min with occasional vigorous shaking.The large flocculent
materialthat formed was precipitatedinamicrocentrifugefor
10min.andtheclearedlysatewastransferredtofresh
microcentrifuge tubes.After addition of 250 0 phenol (pH 8.0) and
250 p.1chloroform/isoamyl alcohol (24:1) and brief vortexing,the
phases were separated by centrifugation ina microcentrifuge for 5
min.The aqueous phase (approximately 500 p.1)was removed to a
fresh microcentrifuge tube,1ml ice cold 95% EtOH added and the
tubes incubated at -200C for 10 min. followed by centrifugation in
amicrocentrifugefor10 min.toprecipitatedthe DNA.The
resulting pellet was washed with 500 0 70% EtOH, dried under
vacuum and subsequently resuspended in 50 µl TE.This procedure53
routinely yielded approximately1gg/j.t1 of plasmid DNA which was
directly used for restriction digests or transformations.
Large Scale Plasmid Preparation
Plasmid DNA from11cultures was isolated as described by
Birnboim and Do ly (9).In brief, cells were grown overnight in11
LB broth,harvested, resuspended inatotalof 10 ml Birnie #1
(5 mM glucose, 2.5 mM Tris, pH 8.0,1 mM EDTA and 10 mg/ml
lysozyme) and incubated at 370C for 30 min.Cells were lysed by
the addition of 20 ml Birnie #2 solution (0.2 N NaOH /1 % SDS) and
incubated on ice with occasional gentle mixing toassure complete
lysis.After 15 min. on ice, 15 ml of 3 M sodium acetatewas added
and the mixture was incubated on ice foran additional 45 min.
with frequent,vigorousshaking.The resultingprecipitate was
collected by centrifugation in a Beckman centrifuge (Model J21-2)
at 10,000 rpm. at 40CThe cleared lysate was removed into clean
centrifuge bottles by pouring it over sterile cheese cloth toremove
the remaining debris and 32 ml of ice cold isopropanolwas added.
Aftera10 min.incubationat-200 C,theplasmid DNA was
precipitated by centrifugation for15 min. (10,000 rpm.at 40C ).
The resulting pellet was dried undervacuum and resuspended in
5ml TOAE (50 mM Tris, pH 8.0,100 mM sodiumacetate,
1 mM EDTA).Plasmid DNA was subsequently re-precipitated by
the addition of 10 ml ice cold 95% EtOH, 10 min incubationat -200C
and 15 min. centrifugation (10,000 rpm., 40C).The resulting pellet54
was washed with5ml 70% EtOH, dried under vacuum and
resuspended in4 ml TE.For furtherpurification,300[1.1of
ethidium bromide (10 mg/ml in water) and 5.2 g CsC1were added
and the solution was filled into Beckman ultracentrifuge tubes, heat
sealed and centrifuged for15hrs.at 58,000 rpm at 200C in a
Beckman ultracentrifuge (Model LM8-70M) usingaverticaltube
rotor (Beckman, VTi 65.2).After ultracentrifugation, two separate
DNA bands formed in the established gradient with the lower band
representingthe plasmid DNA and the upper band representing
chromosomal DNA.Plasmid DNA was removed from the tube with
a 3 ml syringe by carefully inserting an 18 gauge needle (bevel up)
underneath the plasmid band.The ethidium bromide associated
with the DNA was removed by several extractions (usually 5or
more) with equal volumes of water saturated1-butanol.After no
more "pink" (ethidium bromide) was visible in the organic (upper)
phase of the sample, 2 vol. of dds water, 1/10 vol. (water+ DNA
solution) of 3 M sodium acetateand 7/10 vol. (total vol.) of ice cold
isopropanol was added tothe aqueous phase.The mixture was
incubated at 40C for 10 min., centrifuged for 15 min. (10,000rpm.,
40C) and the resulting pellet dried undervacuum.After the pellet
was resuspended in 500 µ 1TOAE, the plasmid DNA was re-
precipitated by the addition of1ml of ice cold 95% EtOH and
centrifugation for 10 min in a microcentrifuge.The plasmid DNA
was washed with 50011 170% EtOH, dried under vacuum and
resuspended in 100 µ1 TE.After spectrophotometric determination
of the quantity of DNA present in the sample, the concentration55
was adjusted to11.1g /µl and the DNA was stored at -200C.DNA
prepared by this method was routinely used for restriction digests,
transformations and cloning experiments.
Total RNA Preparation
Strains were grown to an 0.D.600 of approximately 1.0 and
total RNA was harvested usingthe Quiagen RNeasy kit.The
quantities of RNA were determined spectrophotometrically, where
1.0 O.D. unit at X=260 nm is equivalent to 40 µg /ml of RNA.The
integrity of the RNA was checked by separating an aliquot of the
samples (approximately 5 gg) on a 1% agarose gel under denaturing
conditions (1X TBE electrophoresis buffer: 5.4 g Tris base, 2.75 g
boric acid, 2.0 ml 0.5 M EDTA (pH 8.0)/1 H2O) (91) at 10 V/cm for
45 min.
RibonucleaseProtectionAssay
Construction of vector for production of anti-sense RNA was
as follows:a 420 by Nrul-Clal DNA fragment was isolated from a
pUC18 construct carryingthefulllength rcsAgene (including
upstreamregulatoryregion)(pUC18-rcsA).This fragment was
inserted into the HincII-Clalsites of pBSII-KS(-) (Stratagene, La
Jolla, CA) resultingin pBSII-KS(-)-NCrcsA.The sequence of the
insertedfragment wasverified.Anti-sense rcsA mRNA was56
synthesizedinvitro, using Hincll linearized pBSII-KS(-)-NCrcsA
DNA as template, with the Ambion Maxiscript in vitro transcription
kit,following manufacturer's instructions (Ambion, Austin, TX).
Full length probe was purified on a 5% acrylamide/8M urea gel.
Ribonuclease protection assays were carried out using the Ambion
RPAII kit,following manufacturer's instructions.
Preparation Of Phage Lysates
P 1 virLysates
P1 vir lysates were prepared as described by Silhavy, et al.
(96).Fifty pl of an overnight culture of the strain from which the
lysate was to be prepared was added to 5 ml LB broth containing
0.2% glucose and 5 mM CaC12.After 30 min incubation at 370C,
100 p.1 of Plvir lysate was added and the culture was incubated for
an additional 3-4 hrs.When complete lysis was evident, 100 p 1 of
chloroform was added to the culture and after brief vortexing, the
cell debris was pelleted and the clear phage lysate was transferred
to a clean glass vial.57
A,Lysates
X,lysates were prepared as described by Silhavy (96).A
suitablehostwas grownovernightin LB supplementedwith
0.2%maltoseand10 mM MgSO4(LBMM), harvestedby
centrifugationandresuspendedinanequalvolumeof
10 mM MgSO4. A single plaque of the phage of interest was
removed from an agar plate, added to 50 gl of cells and vortexes
vigorously.After 5 min. at room temperature, 2 ml of LBMM was
added and the culture was incubated at 370C until complete lysis
wasevident(approximately3-4hrs).Aftertheadditionof
100 pl chloroform and slight vortexing to lyse all remaining cells,
the lysate was centrifuged for10 min. and the clear supernatant
transferredtoa clean glassvial.To determine thetiter of the
lysate,10 p1 each of a 10-2, 10-4,10-6, 10-8, 10-10 and 10-1 2
dilution were spotted on a LB agar plate containing a confluent
lawn ofasuitablehoststrainand incubated overnightatthe
appropriatetemperature.
StrainConstructions
Transductions
Transductions were carriedout followingthe procedure of
Silhavy, et al.(96).An overnight culture of thestrainto be58
transduced was harvested by centrifugation and resuspended in
1/2vol. of 10 mM MgSO4 + 5 mM CaC12 and starvedat room
temperature for a minimum of 2 hrs.One hundred gl of cells were
added to 100 ill of P1 lysate and the mixture was incubated at 320C
for 30 min.After the addition of 100 ill1 M sodium citrate and
1 ml LB broth, the culture was incubated for one additional hour at
3 7 0C.Cells were harvested by centrifugation, resuspendedin
100t1 LB + 0.1 M sodium citrate, plated on selective media and
incubated overnight atthe appropriate temperature.
CompetentCells And Transformations
Preparationof competentcellsandtransformationswere
carried out by the CaC12 method as described by Sambrook atal
(91).An overnight culture of thestrainto be transformed was
back diluted 1:100 into 10 ml fresh LB broth and incubated at 370C
until the 0.D.600 reached approximately 0.6 (= mid log phase).The
culture was chilled on ice for 15 min., centrifuged at 5,000rpm.
(40C), resuspended in an equal volume of ice cold 0.1 M CaC12 and
incubated on ice.After 15 min, the culture was centrifuged again,
resuspended in 1/2 the volume of ice cold CaC12 and incubatedon
ice as before.Finally, the cells were pelleted, resuspended in 1/10
the original volume and kept on ice for an additional 15 min. to
establish competency.To transform the cells with plasmid DNA,
approximately 100-500 ng of DNA was mixed with100 µ 1 of
competent cells, incubated on ice for 30-60 min., heat shocked at59
420C for1 min, incubated on ice for 2 min and after the addition of
1 ml of LB broth incubated for1hr at 370C toallow phenotypic
expression of antibiotic markers.Cells were plated on appropriate
selectivemediaandincubatedovernightattheappropriate
temperature.
TransposonMutagenesis
Transposon mutagenesis wascarriedoutasdescribed by
Kleckner, et al.(64).The strainto be mutagenized was grown
overnight in LBMM, cells were harvested and resuspended in 1/10
volume10 mM MgSO4(thisrepresentsacelldensityof
approximately109 cfu/ml) and 100 gl of cellswere mixed with
sufficientA. lysateto achieve a multiplicity of infection (moi) of
approximately1.0. Themixturewasincubatedatroom
temperature for 15 min, followed by 15 min. at 370C to allow for
transposition.After the addition of 100 III of 1 M sodium citrate,
1ml of LBMM was added and the culture was incubated at 370C
for1hr.Cells were collected, resuspended in 100 gl fresh LB
containing 100 mM sodium citrate and plated to selective media.
Thisprocedureyieldedapproximately1-5x103 mutants/109
cells.Multipleplatesof mutants(usually10) were prepared,
colonies washed off the plates with approximately1ml 10 mM
MgSO4, pooled, washed twice with 10 mM MgSO4, resuspended in
1 ml 10 mM MgSO4 and 50 ill of this pool of mutantswas used to
prepare a Plvir lysate as described above.60
Detection Of RcsA And RcsA*
Strains were grown in LB broth (containing the appropriate
antibiotics)to an 0.D.600 of approximately 0.6.One ml samples
were removed, washed in10 mM MgSO4,resuspended in 100 p1
SDS-PAGE samplebuffer (3% SDS, 5% (3-merc ap to e th anol
0.00025% bromophenolblue,10% glycerol,0.5M TrispH6.8)
containing (91) and boiled for 10 min.Protein concentrations were
determined forallsamples usingthe Bicinchoninicacid (BCA)
protein assay method (Pierce, Rockfort, IL).Equal amounts of total
cellular protein (30 p,g) were fractionated on a 14% tricine SDS
polyacrylamidegel(92). Proteinsweretransferredto
polyvinylidene difluoride membrane (PVDF; Dupont NEF-1000) in
10mM CAPSbuffer(pH11)(3-(cyclohexylamino)-1-
propanesulfonicacid)supplementedwith 20% methanol(112).
After transfer, membranes were briefly air dried and subsequently
blocked in Tris buffered saline (20 mM Tris, pH 7.4, 125 mM NaC1)
containing 0.1% Tween 20 and 1% nonfat dry milk (TBSTM).Blots
were incubated in TBSTM with pre absorbed polyclonal antiserum
specific to E. coli RcsA, washed 3 times in TBSTM and incubated
with an appropriate dilutionof monoclonal goat antirabbit IgG
conjugated to horseradish peroxidase (American Qualex, La Mirada,
CA) in TBSTM.After 3 washes with TBST, immunoreactive proteins
were visualized on autoradiographicfilm (Hyperfilm, Amersham,
Arlington Heights,IL)using enhanced chemiluminescence (ECL,
Amersham) according to manufacturers instructions.61
RcsA And RcsA* Turnover And Half-Life Determination
Strainswere grownat320 CinLB(withappropriate
antibiotic)to an O.D.600 of approximately 0.7.To arrest protein
synthesis,spectinomycin was addedtoafinalconcentration of
10 p, g/ml (33)and a1ml sample was taken immediately and
processed as described above (t=0).Cultures were kept at 320C
and after new protein synthesis was arrested (10 min.), additional
samples (t=1,2,5,10,15, 30 and 60 min.) were taken, processed
and analyzed as described above.To assess the efficient arrest of
proteinsynthesis,the O.D.600 of the culture was monitored after
addition of spectinomycin and compared to the O.D.600 of a portion
oftheculturethat was nottreatedwithspectinomycin.To
determine the half-life of RcsA protein,the relative quantities of
RcsA protein for each time point was determined by scanning the
film with densitometer (Molecular Dynamics Personal Densitometer
S/).The intensity of the RcsA protein bands at each timepoint was
determinedusingthe"Volumereport"analysistoolofthe
Molecular Dynamics Image QuaNTTM scanner software.Values were
normalized by assigningthet=0 time pointavalue of1and
expressingallothertimepointsasafractionofthisvalue
(i.e.% proteinremaining).Assumingasimpleexponential
relationshipfortheLon dependentdegradationof RcsA,the
reaction can be described by the general equation
(1) f(x) = eb * e-kt62
where k is the rate constant, b isa correction factor for t=0 time
point and t= time in minutes.
To determine k and b, the values representing the ln(f(x)) of
the first 6 time points were plotted versus time.Linear regression
performed on these data resulted instraightlines represented by
the general equation
(2) ln(f(x)) = -kx + b
where k = to the slope and b represents the y intercept.
The values for k and b were inserted into (1).To determine
thehalf-life of the RcsA proteins the equations obtained in(2)
were solved forf(x) = 0.5(i.e. 50% of the protein remaining)
(t112 = ln(0.5)/k) and the determined values represent the half-life
of the protein in minutes.
13-GalactosidaseAssays
Strains were grown in LB broth (containing the appropriate
antibiotics) to an O.D.600 of approximately 0.3-0.7 and assayed as
describedbyMiller.(74).Oncetheculturesreachedthe
appropriate 0.D., they were chilled on ice for 20 min., the O.D.600
was determinedand0.1-1mlofculture(dependingonthe
expected13 -galactosidaseactivity)wasdilutedwithsufficient
Z-Buffer (0.06 M Na2HPO4, 0.04M NaH2PO4, 0.01 M KC1, 0.00163
M g SO4 and 0.05 M 3 mercaptoethanol, pH 7.0) to make 1ml, 2-3
drops of toluene were added to permeabelize thecells and after
vigorousvortexing(>30s.)thetoluenewasevaporatedby
incubating the samplesat 370C for 45 min.Following 5 min at
280C, 200 111 of a4 mg/ml o-nitrophenylfl D-galactoside (ONPG)
in0.1 M phosphate buffer (pH 7.0) was added (t=0) and the
development of a yellow color was observed.Once the samples had
turned sufficiently yellow, 0.5 ml of 1 M Na2CO3 was added (t=1)
and the optical densities of the samples at 420 nm and 550 nm
were measured.0-galactosidaseactivitieswerecalculated
according to the following formula:
(3)Units = 1000 x0.D.420 - 1.75 x 0.D550
tx v x 0.D.600
where t = time of the reaction in minutes and v = volume of culture
used in the assay in milliliters.
Threeindependentisolatesof eachstrainwereassayed,
values represent the mean of these assays.
Construction Of rcsA::lacZ And cps::lacZ Promoter Fusions
rcsA and cps promoter fragments, either with or without the
"RcsABox", were amplified using SG20250 chromosomal DNA as64
template and the following primers: rcsANoBoxF 5' CCG AAA AAG
AAT TCC TAC GA 3', rcsAR 5' GGC GGA CTT AGG ATC CCG TA 3',
cpsBoxF 5' CAA CCT AAA GGA ATT CCT AA 3', cpsNoBoxF 5' GCC
AAT TAC CGA ATT CTT AT 3' and cpsR 5' CCG TCT CAG GAT CCA GTC
GT 3'respectivelyusingthe polymerase chainreaction.All
forward primers were designed to include an EcoRI restriction site,
whilethereverse primers containeda BamHI restrictionsite.
Reaction mixtures (100 111) containing 30 ng DNA template, 0.5 11M
of each primer, 1.5 mM MgC12, 5% Acetamide, 200 11M dNTPs and
2.5U Taq DNA polymerase were incubated for 35 cycles (1 min. at
940C, 1 min at 550C and 3 min at 720C) following a hot start cycle
(5 min at 940C followed by 2 min at 800C).Amplification products
were digested with EcoRI and BamHI, purified with Quiagen PCR
purification kits and ligated into pUC18 cut with EcoRI and BamHI.
Recombinant plasmids were isolated, inserts verified by restriction
digests followed by agarose gel electrophoresis (1 % gel for1hr at
10 V/cm in1 X E-Buffer [4.84 g Tris base, 1.14 ml glacial acetic
acid, 2 ml 0.5 M EDTA (pH 8.0)/L H2O]) and the inserts sequenced
on an ABI377 automated sequencer withtheuniversal forward
and reverse primers (sequencing reactions were carried out at the
CenterforGene Research and Biotechnologycentralservices
laboratoryat Oregon State University).Promoter fragments with
the correct sequence were subcloned from pUC18 into pRS415 (97).
TheresultinglacZoperonfusions(pRS415-rcsANoBox,
pRS415-cpsBox and pRS415-cpsNoBox) were crossed onto A RS45 as
follows:50 g 1ofaJT4000culture,transformedwiththe65
recombinant plasmids, wasinfectedwithA RS45 at an moi of
approximately1.0 and incubated at room temperature for 5 min.
Two ml of LBMM were added and the culture was incubated at
370C until complete lysis of the bacteria was evident.Remaining
cells were lysed by the addition of 100 p.1 of chloroform and brief
vortexing, followed by a 5 min. centrifugationstep.To isolate
recombinant phages,1,10 and 100p.1of the lysate were mixed
with 100 p 1of JT4000 culture,100 plof 20 mg/ml 5-bromo-4-
chloro-indolyl-P -D-galactoside (X-Gal) and 3 ml of melted top agar
(LB broth + 0.7% agar), plated on LB agar and incubated at 370C
overnight.Blue plaques were picked and purified by preparing a
lysate,which was subsequently platedoutasdescribed above.
Oncea purelysate,resulting fromasingle,blue plaque was
obtained,the lysate was titered and the presence of the correct
insertsize was determined usingthe polymerase chain reaction
with the following primers specificto regions upstream (RS45F)
and downstream (RS45R) from the promoter regions of the fusions:
RS45F 5' GGA ATT GGG GAT CGG AAT TC 3'; RS45R 5' CGA CGG CCA
GTG AAT CCG GT 3'.PCR reactions were carried out as described
above with the following modifications: 10 p.1 of a 1:100 dilution of
the phage lysates(approximately1x109 pfu/ml) was used as
template and the annealing temperature was raised to 650C.Once
theinsertswere verified,thefusions were introducedintothe
chromosome of SG20250 at the A att sitefollowing the procedure
describedbySimons, et al.(97).One hundred p 1of a fresh
SG20250 overnight culture in LBMM was mixed with 100 p1 of66
phage stock (>106 pfu/ml) and incubated at room temperature for
20 min., 2 ml of LBMM was added and the culture incubated for
2 hrs at 370C before plating dilutions of 10-3 to 10-8on LB + X-Gal
(3 ml of 20 mg/ml stock/L of agar) plates and incubating them
overnight at 320C.Individual blue colonies were purified and the
presence of the correct size fusion in the chromosome was verified
usingthepolymerasechainreactionwithchromosomal DNA
(30 ng) from eachstrainastemplate with PCR conditionsas
described above.Prophage copy number was determined using the
Ter test (79, 97).Two hundred µ1 of a fresh overnight culture of
thelysogens was mixed with 200[t 1ofheteroimmune phage
(Aim m 434 c ;109pfu/ml) and incubated for 20 min at room
temperature.Fifty[t 1of this mix was transferred to 2.5 ml fresh
LBMM, incubated for an additional 2 hrs. at 370 C and lysed with
3 drops of chloroform and slight vortexing.The resulting lysate
was spot titered on a lawn of SG20250-Aim m 434 to determine the
resulting titer of imm 21 phage.Non-infected control cultures were
treatedinthe same fashiontodetermine levelsof spontaneous
prophage induction.The data from the Ter test, in conjunction with
the levels of f3 -galactosidaseactivity determined for eachisolate,
allowed for the identification of single copy lysogens (those with
the lowest [3-galactosidaseactivity and thelowesttiter),which
were used for all subsequent experiments.67
Targeted Mutagenesis Of The rcsA Gene
E.coli CAG18451, which carries a Tn/O near the wild-type
rcsAgene (zed-3069::Tn10) (98),referredtoasT38, was
mutagenized using N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)
(Aldrich, Milwaukee, WI) following the procedure described by
Silhavy, et al.(96) withslightmodifications: A T38 overnight
culture was back diluted1:50, grown tolate log phase (0.D.600
approximately 1.0) and 2 ml of this culture were added to a test
tube containing 50 111 of nitrosoguanidine (2.5 mg/ml in 95% EtOH)
and mixed well.After 10 min at 370C, theculture was washed
twice with 2 ml of M63 broth, resuspended in 5 ml LB broth and
incubated at 370C overnight.The overnight culture was used for a
secondroundofnitrosoguanidinemutagenesis,followingthe
identical procedure.After the second overnight incubation, 50 ill of
the mutagenized culture was infected with bacteriophage Plvir.
The resulting Plvir lysate was used to transduce E. coli S G2 07 8 O.
Tetracycline resistant transductants were selected on MacConkey's
Lactose agar plates and screened for a change from a lac- (white) to
a lack (red) phenotype.
Determination Of rcsA* Sequences
The sequences of the rcsA* alleles were determined by direct
sequencing of PCR products spanningthecomplete rcsA open68
reading frame generated with the primers RcsAF1 5' GGC GCA TTA
GGT GAC CCA TG 3' and RcsAR1 5' GAG GCA GGG CAT CAG GAC GG 3'
and chromosomal DNA isolated from strains WE100-WE129 as
templates.The resulting 624 by PCR fragments were purified with
Quiagen PCR purification columns and both strands were sequenced
with primers, RcsAF1, RcsAF2 5' GAT GAA TAT CTA TTG GTC AG 3',
RcsAR1 and RcsAR2 5' GAA TAT CGC CAA GGA TAT CG 3',
generating overlapping fragments.After manual editingof the
sequences ("seqed" of the GCG sequence analysis package) (20)
generated by automated sequencing on an ABI 377 automated
sequencer (CGRB centralserviceslabatOSU),theindividual
sequences were assembled into two contigs representingthetop
and bottom strand of the rcsA*alleles,usingthe"sequence
assembly"programofthe GCG sequenceanalysispackage.
Mutations in the rcsA ORF were identified by comparing the newly
generatedrcsA* sequencestothewild-typercsAse quence
(GenBank accession # M58003) using the GCG program "bestfit".
Sequencing of the promoter region of the rcsA* alleles was carried
out in the same fashion, using a PCR fragment generated with the
primers rcsAUF 5' GTG AAA TTT TGA ATT CGC TG 3' and RcsAR1
and sequenced with primers rcsAUF and RcsAR2.69
Results
Saturation Of Lon Protease
Saturation of Lon protease with one of its substrate has been
hypothesizedtoprotectothersubstratesfrom Lon dependent
degradation (19).Dervyn, et al.(19) demonstrated that lon+ cells
expressing high levels of Su1A protein from a multicopy plasmid
expressed high levelsof capsular polysaccharide.This mucoid
phenotypeisconsistent withthestabilizationof asecond Lon
substrate, RcsA, a positive regulator of capsule synthesis (109).In
lon+ cells RcsA is rapidly degraded and cannot realize its biological
function.Huisman and coworkers proposed that high levels of Su1A
saturate Lon protease, thus protecting RcsA from Lon dependent
degradation.To challengethishypothesis,E.coli lon+ c ells
expressing high levels of RcsA proteinwere exposed to a variety of
DNA damaging agents in order to assess their sensitivity to these
agents(presumablyanindicatorof SulAaccumulation).To
saturate Lon protease,E.coli lon+ cellswere transformed with
pATC400 (116), a pBR322 derivative containing the complete rcsA
open reading frame (ORF) in addition to the upstream regulatory
region.Cells transformed with this plasmid express high levels of
RcsA,asevident by theobservationthatthesecellsarevery
mucoid.Table 3.Saturation of Lon protease with RcsA does not protect Su1A from Londependent degradation.
Relevant genotypea
Alon cps.B10::lacZ
Alon cpsBio::lacZ
lon+ cpsBio::lacZ
lon+ cpsBio::lacZ
plasmid
MacLacb
PHENOTYPES
Mit Ce UVe MMSd
pBR322
pATC400 (rcsA+)
+
+
pBR322 + + +
pATC400 (rcsA+) + + +
aStrain designation (MC4100 derivatives: Alact 1169 araD flbB rel).
SG20781: Ion+ cpsB113::lacZ; SG20780: Alon cpsBio::lacZ
Measured on MacConkeys Lactose agar plates.This test is an indication of the activity of the
cpsBio::lacZ fusion. + = Lac+ (red), fusionon;= Lac- (white), fusion off.
cMeasured on LB agar plates containing 50µg /ml ampicillin at 320C.
This test is an indication of RcsA stability. = not mucoid; + = mucoid.
Measured on LB agar plates containing 50 lag/m1 ampicillin. UVwas delivered as described by J.
Miller.This test is an indication of Su1A stability.= no growth;+ = growth.
eMeasured on LB agar plates containing 0.05% methylmethane sulfonate. Thistest is an indication of
SulA stability.-= no growth; + = growth.
f Measuredon LB agar plates containing 0.5 mg/ml Mitomycin C. This test is an indication of SulA
stability.-= no growth; + = growth.
b
d
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Mucoidy was assessed as the activity of a cpsB j 0 ::lacZ operon
fusion(reportingtheactivityof thecapsule (cps)genes as a
functionof(3-galactosidase)(Table3,line4)orbyvisual
assessmentoftheamount of capsular polysaccharide produced
(data not shown).In addition, in cells containing pATC400, RcsA
protein was readily detectable using Western blot analysis of whole
cellextracts(data not shown), whereas incellscontainingthe
parent plasmid (pBR322) RcsA protein was not detectable (data not
shown)andthesecellsdonotexpressthecpsB10::lacZ
transcriptional fusion (Table 3, line 3).The observation that RcsA
protein, expressed from a high copy number plasmid, is detectable
in lon+ cells and thus availabletorealizeitsbiological function
-activationofcps expression-suggeststhatLonproteaseis
saturated by this amount of RcsA protein present in lon+ cells.
To assessthesensitivity of thesestrainstovarious DNA
damaging agents, they were grown in the presence, or exposed to,
various agents as explained in Materials and Methods.The results
of these experiments are summarized in Table 3.E. coli dlon cells
are mucoid andsensitivetothe DNA damaging agents MMS,
Mitomycin C and UV light, whether or not they harbor pATC400
(Table 3, lines1 and 2).lon+cells harboring pBR322 are non-
mucoid and resistant toall three DNA damaging agents (Table 3,
line 3).lon+ cells overexpressing RcsA from a multicopy plasmid
are mucoid butresistanttothe DNA damaging agents MMS,
Mitomycin C and UV light (Table 3, line 4).These cells grow as well
in the presence of the alkylating agents MMS or Mitomycin C or72
recover from the exposure to UV light, as do lon+ cells, harboring
the parent vector pBR322.Saturation of Lon protease with RcsA
does not appear to protect SulA from Lon dependent degradation
and,therefore, ion+ cells expressing high levels of RcsA do not
exhibit a Ion- phenotype with respect to SulA (sensitivity to DNA
damaging agents).
Targeted Mutagenesis Of rcsA
Results from saturationstudiesindicated Lon exhibiteda
preference for certain classes of substrates.However, to date, no
informationisavailableastothemechanism by which Lon
protease selects its physiological substrates.Itis impractical to use
site directed mutagenesis to identify residues in RcsA which play a
roleintheinteractionof RcsA and Lon.However, random
mutagenesis of theentire rcsA gene allows for the selection of
mutants which retaintheir biological function (activation of cps
expression) but are no longer degraded in a Lon dependent fashion,
as evident by the mucoid phenotype of cells carrying these alleles
in a lon+ background.In order to accomplish this goal, a technique
known as targeted mutagenesis was used as illustrated in Figure 3.73
E. coli rcsA + - Tn 10
Tn 10
rcsA
Package 100 kb
portions of the
chromosome
into
bacteriophage P1
Transduce into aIon + cpsBio::lacZ
E. colistrain
Select tetracycline resistance
Screen on MacLac for redlon + colonies
Figure 3. Schematic representation of targeted mutagenesis.74
E. coli CAG 18451, a strain carrying a Tn/O insertion in a gene near
rcsA (98), was exposed to the alkylating agent N-methyl-N'-nitro-
N-nitrosoguanidine (MNNG) which generates 06-methylguanine,
leading primarilyto G:C to A:T transitions.The mutagenized
culturewasinfectedwithbacteriophagePlvir, leading tothe
formation of a Plvir transducing lysate.This Plvir lysate was used
to infect E.coli SG20781 (lon+ cpsBio::lacZ), andtetracycline
resistant colonies were selected on MacConkey's Lactose agar plates
containing 25 1.1g/m1 tetracycline.The transposon in CAG18451 is
60% linked to the rcsA gene, meaning that upon transduction, in
60% of tetracyclineresistanttransductantsthe rcsA gene was
cotransduced with the transposon contained in gene zed3069. The
transductantswerescreenedforconversion fromlac- to lac+
phenotype whitetored on MacConkey's Lactoseagarplates),
indicating the cpsBio::lacZ transcriptional fusion is expressed in the
presence of Lon protease.Of 10,000 transductants screened, 30
exhibited a stable lac+ phenotype which could be moved with the
expected frequency of 60% intoa new strain by means of P1
transduction.Mutations in rcsA are hereafter designated as rcsA*,
the 30 isolates were designated WE100 (rcsA* 100) to WE129 (rcsA*
129).Initial characterization of the rcsA* mutants was based on the
levels of expression of the cpsBio::lacZ transcriptional fusion in lon+
cells.Results for this experiment are shown in Figure 4.=*
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Figure 4.Grouping of RcsA* strains according to their levels of
cpsBio::lacZ activity in Ion+ cells.
All E.colistrainsare MC4100 derivativescarryinga
cpsBio::lacZfusion.The relevant genotype of the controls are as
follows:
WE18 (Alon); WE19 (lon+); WE14 (Alon rcsA::ATn10);
WE15 (Ion+ rcsA::ATn10).
P-galactosidaseassayswerecarriedoutasdescribedby
Miller (74).Cells were grown at 329C in LB broth containing 25
µg /ml tetracycline.Specific activityis expressed in Miller units.
The values represent the mean of three assays.
Designationsfortheexperimentalstrainsareasfollows:
O<X<50: RcsA*strainswithspecific0-galactosidaseactivities
between 0 and 50 Miller Units.50<X<100: RcsA* strains with
specific 13-galactosidase activities between 50 and 100 Miller Units.
X>100: RcsA* strains with specific D-galactosidase activities greater
than 100 Miller Units.76
The rcsA* mutants can be grouped intothreecategories,those
which show an increase of cpsBio::lacZexpression between 0 to 50
fold above wild-type (low), those with cpsBio::lacZlevels 51 to 100
fold higher than the wild-type (medium) and those mutants with
cpsBio::lacZexpression levels greater than 100 fold above that
seen in the wild-type strain (high).The majority of mutants (13 of
30 or 43%) fall into the "medium" range with mutants in the "low"
category making up 37% (11 of 30) and those in the "high" category
representing 20% (6 of 30).Inadditiontothe assessment of
capsulegeneexpression,measuredastheactivityofthe
cpsBio::lacZ fusion, the extent of capsule production was assessed in
E. coli SG20250 (Ion+ cps+) by visually assessing the amount of
capsular polysaccharide produced.All mutants are able to direct
the production of capsular polysaccharide, with those in the "high"
category producing the largest quantities of the capsule (data not
shown).In addition to their capsule phenotype, all rcsA* mutants
were screened for their resistanceto DNA damaging agents and
found to be resistant to MMS and Mitomycin C (data not shown).
Expression of the cpsBio::lacZ transcriptional fusion in a lon+
strain background isconsistent with the presence of RcsA protein
in these cells.To test this prediction a Western blot approach was
used to assess the steady state levels of RcsA* protein instrains
WE100-WE129.Figure5depictsa Western blotrepresenting
members of all three classes of mutants.77
Figure 5.Western blot detection of RcsA* in lon+ cells.
To examine RcsA expression, cells were grown to an 0.D.600 of
1.0 in LB containing 25 µg /ml tetracycline at 32°C, or LB containing
50ii g/mlampicillinand251.1 g/mltetracyclineforstrains
containing pATC400.All strains are MC4100 derivatives.
Forallcultures,aliquots were removed and preparedfor
Tricine-SDS-polyacrylamidegelelectrophoresis. Protein
concentrations were determined by the Bicinchoninic acid (BCA)
protein assay method (Pierce).Equal amounts (30 ug) of protein
(except for Lane1which had half the amount of protein loaded)
from whole cell extracts were boiled in sample buffer, fractionated
on a 14% Tricine-SDS-polyacrylamide gel, and analyzed by Western
blot with preabsorbed polyclonal antiserum specific to E. coli RcsA
protein.Immunoreactiveproteinswerevisualizedby enhanced
chemiluminescens (ECL).
Lanes:
1, WE19 (lon+ rcsA+ ) + pATC400;2, WE18 (Alon rcsA+ );
3, WE19 (lon+ rcsA+); 4, WE102 (lon+ rcsA*102);
5, WE110 (lon+ rcsA*110);6, WE114 (lon+ rcsA*114);
7, WE125 (lon+ rcsA*125); 8, WE128 (lon+ rcsA*112);
9, WE103 (lon+ rcsA*103)kD
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Based on the Western blot approach, the RcsA* strains can again be
grouped into three groups, those mutants with no detectable levels
of RcsA protein,those with medium levels of RcsA protein and
those with highlevelsof RcsA protein.RcsA protein hasa
predicted molecular weight of 23.5 kDa and migrates on SDS
polyacrylamidegels(109)atanapparent molecular weightof
approximately. 27 kDa.As determined by Dierksen and Trempy
(22), RcsA existsin two separate forms,differingin molecular
weight by approximately1kDa.Both forms can be visualized on
Western Blotsif glycine inthe cathode bufferisreplaced with
tricine during SDS PAGE as described in materials and methods.
Lane 1represents a lon+ strain expressing RcsA from a multicopy
plasmid.In thisstrain RcsA protein is readily detectable due to
high level expression or rcsA and thus presumably saturation of
Lon protease.Lane 2 represents the RcsA protein profile of a Alon
strain and again RcsA is readily detectable, however, in this strain
RcsA isstabilized due to the absence of Lon protease.Lane 3
represents a lon+ strain expressing RcsA only from a single copy of
the rcsA gene.In this strain, no RcsA protein is detectable.The
datarepresentedinLanes1-3correspondwithpreviously
published results(109).Lanes 4 through 9 represent 6 RcsA*
isolates, with WE102 from the "low" category (Lane 4), WE110,
WE114 and WE125 from the medium category (Lanes 5-7) and
WE128 and WE103 from the "high" category (Lanes 8-9).From this
dataitisevident that members of rcsA* mutant class2 and 3
(medium and high) have levels of RcsA* protein which are readily80
detectable in the presence of Lon protease, as compared to wild-
type RcsA which is not detectable in the presence of Lon protease.
rcsA* mutants in category1("low"), even though they do express
the capsule genes at levels up to 50 fold higher than the parental
strain, have no detectable RcsA* protein.For most of the rcsA *
strains,the grouping into one of the three classes, based on the
levels of cpsBio::lacZexpression and levels of detectable RcsA*
protein corresponds well, with only few exceptions.
RcsA And RcsA* Turnover
The steadystatelevelsof RcsA* protein observed inthe
rcsA *mutants,inconjunctionwiththeincreasedlevelsof
cpsBio::lacZ expression indicate an increased stability of the RcsA*
protein.However, neither assay evaluates the true stability of the
RcsA* protein with respectto Lon dependent degradation.To
assessthestabilityof the RcsA* proteins, aninvivoturnover
experiment was carried outto determine the quantity of RcsA*
protein over a time course of 60 min.As described by Geuskens, et
al.(33), the addition of spectinomycin to a culture arrestsall new
protein synthesis, therefore, any protein detected in samples taken
aftertheadditionof spectinomycin representsproteinthat was
synthesized prior to the arrest of protein synthesis.Since no new
protein synthesisistaking place,this approach can be utilized to
followthepersistenceofaproteinovertime.Turnover
experiments were carried out only for those rcsA *mutants which81
had detectable steady state levels of RcsA* protein and for lon+ and
a Alon control cultures.For those rcsA* strains with no detectable
steady state levels of RcsA, a turnover experiment does not provide
any information, since no RcsA protein is detectable.Figure 6 is a
composite of theresults from these experiments.As mentioned
earlier, steady state levels of RcsA protein in a lon+ strain are not
detectable and therefore no RcsA protein is detectable in the course
of theturnover experiment (Figure6a,t=0 through t=60 min.).
Included in this experiment as a control is an extract from a Mon
strain (Figure 6a, Lane 1)to demonstrate proper functioning of the
Western blotting technique.Figure 6b represents the results of a
turnover experiment with extracts prepared from a Mon strain.
RcsA protein is detectable in thisstrain background throughout the
course of the experiment (60 min.).Figure 6c-h represent the
resultsof turnover experiments forstrains WE108 (6c), WE110
(6d), WE112 (6e), WE113 (6f), WE114 (6g) and WE125 (6h).All
other RcsA* strains(with detectable steady statelevels of RcsA)
had nodetectable RcsA proteinafter1min.oftheturnover
experiments(t=1)andthereforenohalf-lifechangecouldbe
determined (data not shown).The data forstrains WE127 and
WE128 are not shown, both these strains were determined to be
identical to WE112 (see below).82
Figure 6.RcsA and RcsA* turnover in vivo.
Cultures were grown to 0.D.600 of approximately 0.7,1ml
sampleswereharvestedbefore(t=0)andafteradditionof
Spectinomycin (100 µg /ml final conc.) (t=1, t=2, t=5, t=10, t=15,
t.30 and t=60 min.) and prepared for Tricine-SDS-polyacrylamide
gel electrophoresis.Protein concentrations were determined by the
BCA protein assay method (Pierce).Whole cell extracts were boiled
insample buffer and equal amounts of protein(30j.t g)were
fractionated on a 14% Tricine-SDS-polyacrylamide gel and analyzed
by Western blot with polyclonal antiserum specific to E. coli RcsA
protein.Immunoreactive proteins were visualized by ECL.
a) WE19 (lon+ rcsA+), b) WE18 Won rcsA+);
c) WE108 (lon+ rcsA*1";d) WE110 (lon+ rcsA*110);
1.c.sA*112\; 0 e) WE112 (lon+ ) WE113 (Ion+ rcsA*113);
g) WE114 (lon+ rcsA*114),h) WE125 (lon+ rcsA*125).a)
Alon
t=
0
b)
ton+ Alon
t= t= t= t= t= t= t=
0 1251 0 30 60mint= t= t= t= t= t= t=
0 1251 0 3 0 60min.
williMOOMr
0 l25101530 60 min. 0 125101530 60 min.
Figure6.
g)
IMO ell fi,*
) rat all all
8384
For all RcsA* strains a new timepoint (t=10 min.) was included in
theexperimenttoassuresufficientdatapointswithdetectable
RcsA protein for half-life determination.For WE108 (Fig. 6c), RcsA
protein was detectablefor 30 min.;for WE110 (Fig.6d) RcsA
protein was detectable for 30 min.; WE112 (Fig. 6e) had detectable
RcsA protein over the entire course of the experiment (60 min.)
with the quantities of RcsA not diminishing over time.WE113
(Fig.6f) had detectable levels of RcsA protein fora period of
30 min.; WE114 (Fig. 6g) had detectable RcsA levels for 30 min.
The last mutant tested was WE125 (Fig. 6h) with detectable RcsA
levels for 15 min.
To better evaluate the data, the films were scanned and the
resulting data transformed as described in Materials and Methods.
Figure 7isa graphic representation of the turnover data.For
claritythegraph onlydepictsthevaluesfor mutants WE108,
WE112, WE114 and WE125 in additionto the values for WE18
(lon +) and WE19 (Mon). No RcsA protein can be detected in a lon+
strain and therefore no half-life can be determined for RcsA in this
strain.In a Mon strain degradation of RcsA protein is dramatically
reduced but not completely abolished.The half-life of RcsA in a
Mon strain was determinedtobe approximately 23 min.This
valuecorrespondswellwithpreviously publishedresultsofa
30 min half-life for RcsA in a Mon strain (109).85
Figure 7.RcsA and RcsA* stability and half-life determination.
To assess the half-lives of RcsA and RcsA* proteins, the films
shown in Figure 6 were scanned on a densitometer and the raw
data was transformedasdescribedinMaterialsand Methods.
Strains are as follows:
WE19 (lon+ rcsA+); WE18 Won rcsA+); WE108 (lon+ rcsA*108);
WE110 (lon+ rcsA*110);
WE112 (lon+ rcsA*H2) ;WE113 (lon+ rcsA*113);
) rcsA*114, WE114 (lon+ WE125 (lon+ rcsA*125).WE 18
-M-- WE 19
--Ar- WE 1 08
WE1 1 0
WE1 12
WE113
WE114
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The turnover data allowed the rcsA * mutants to be grouped into
three groups, those with stable RcsA* protein ina lon+strain
(WE112), those with RcsA* protein which isstill degraded, but had
asignificantly increased half-lifeina lon+ strain(WE125) and
those with detectable RcsA* protein but ahalf-life of lessthan
1min. as compared to the half-life which is observed for wild-type
RcsA protein in a lon+ strain (WE19).The half-life of RcsA* protein
in the second classis approximately 5 min.The half-life for the
RcsA* protein produced by WE112 could not be determined, since
the quantities of protein did not diminish over the period of the
turnover experiment (60 min.).The addition of a 2 hr timepoint
did not clarify this issue, since the quantity of RcsA* protein did
not change (data not shown).Based on the results of the invivo
turnover experiments, further analysis of the rcsA* mutantswas
limited to the six mutants with detectable levels of RcsA* protein
past t=1 in the presence of Lon protease (WE108, WE110, WE112,
WE113, WE114 and WE125).Table4summarizesthedata
gathered on these six mutants as well as for the Mon (WE18) and
lon+ (WE19) control strains.
Sequencing Of rc s A* Mutant Alleles
To determine the sequence changes introduced into the rcsA
genes during the targeted mutagenesis protocol, a fragment slightly
larger than the complete rcsA open reading frame was amplified88
using the PCR primers and according to conditions described in
Materials and Methods.
Table 4.Summary of data gathered for six rcsA * mutant strains.
Strain n-gal.activity Rel. quant. half-life
(Miller Units)a of RcsAb (min.)c
WE18
WE19
164
1
23
<1
-HH-
WE108 56 ++ <1
WE110 61 ++ 2
WE112 271 >120 IIIII
WE113 72 <1 -1H-
WE114 72 <1 -H
WE125 68 ++ 5
a I3-galactosidase assays were carried out as described by Miller
(74) and represent the average of three independent assays.
b symbols are as followsno visible capsule;++ slightly mucoid;
+++ mucoid; ++++ very mucoid; +++++ copious amounts of capsule.
C half-lives are from graphs in Figure 6.
Purified PCR products were sequenced at the OSU CGRB central
serviceslabonan ABI 377automatedsequencerwiththe
sequencing primersdescribedinMaterialsand Methods.The
design of the PCR primers was such that the fragment generated is
large enough to allow sequencing of the entire rcsA open reading89
frame.Both strands of the fragments were sequenced with two
primers eachtogenerate overlapping fragments.The sequences
generated were visuallyanalyzed and existingambiguities were
eliminated wherever possible.Fragments representing the top or
bottomstrandof each mutant were convertedintocontiguous
sequences using the GCG sequence analysis package.Discrepancies
between the two sequences were analyzed on the original sequence
printouts and, if possible, eliminated.Once a contiguous sequence
for both top and bottom strand was created, these sequences were
compared
package.
sequence
compared
program.
to each other using the"bestfit" program of the GCG
This alignment allowed the removal of any remaining
ambiguities Thenewlygeneratedsequencewas
tothewild-type rcsAsequenceusingthe"bestfit"
If ambiguities between the top and bottom strands could
not be resolved, the PCR fragment was resubmitted for sequencing
with the two primers spanning the area of the ambiguity.The
mutations identifiedin the rcsA*alleles and the changes in the
primary amino acid sequence of RcsA they cause are summarized
in Table 5.WE112, the rcsA*mutant with stable RcsA* protein
was determined to have a single base change at nucleotide 435 of
the rcsA ORF.The change from a guanine toa thymine isin
accordance with the mutagenesis protocol (MNNG causes mainly G:C
to A:T transitions).The change of nucleotide 435 leads to a change
in the primary amino acid sequence of RcsA: methionine 145is
replaced by an isoleucine residue.WE125 has a single base change,
adenine 541is replaced by a cytosine, changing amino acid 18190
from lysine to glutamine, a change from a basic amino acid toan
uncharged amino acid.All mutations in the rcsA open reading
frame leading to the synthesis of an RcsA protein withan extended
half-life are located in the C-terminal portion of the RcsA molecule.
WE108, WE110, WE113 and WE114 had no changes in the rcsA
ORF.
In addition to the rcsA ORF, the rcsA promoter regionwas
sequenced following a similar approach as described for the ORF. A
fragment containing the rcsA promoter region was amplified using
the primers RcsAR2 and RcsAUF.Purified PCR products were
sequenced using the same primers and analyzedas described for
the rcsA ORF.The sequence upstream of the rcsA ORF was
compared to the promoter sequence of rcsA published by Sledjeski,
et al.(100).WE112 and WE125 had no change in the promoter
region.WE113 and WE114 were shown to have the same single
basechange,thecytosineatposition-17(counted fromthe
transcriptionalstartsiteas determined by Sledjeski, et al.(100))
was replaced with a thymine.The mutation in WE113/WE114 is
located between the -10 and -35 regions of rcsA promoter.No
change in the promoter region of WE108 and WE110 could be
detected.91
Table 5.Summary of nucleotide and amino acid changes associated
with rcsA* mutants.
S train nucleotide changea amino acid changeb
WE108 none detected
WE110 none detected
WE112 G 435 T M 145 I
WE113/114 C -17 T -c
WE125 A 541 C K 181 Q
a positive numbers refer to the nucleotide in the rcsA ORF with A of
the start codon being nucleotide 1;negative numbers are
according to the numbering by Sledjeski, et al. (102) with the
transcriptional start site being nucleotide +1.
b amino acids are given in single letter code
this change is in the rcsA promoter region and therefore does not
cause a change in the primary amino acid sequence
Detection of RcsA* in a lon+ rcsI3-Strain
RcsB, a second transcriptional activator of cps expression,is
proposed to interact with RcsA to activate cps expression(109).
The interaction of RcsB and RcsA has been proposed to partially
protect RcsA from Lon dependent degradation (109), as the half-
lifeof RcsA increasesinastrain overproducing RcsB from a
multicopy plasmid.In addition, RcsA synthesized from a multicopy
plasmid appears to be lessstable ina lon+rcsB-strain when
compared to a lon+ rcsB+ strain (109).rcsA * mutants, isolated on
the basis of their ability to activate cps expression in a lon+ rcsB+92
strain, might represent mutants with changes inthe RcsA protein
which allow for a tighter RcsA/RcsB interaction,thus protecting
RcsA from Lon dependent degradation.To testthishypothesis,
steady statelevels of RcsA protein from ion+ rcsA*rcsB- were
evaluated by Western blot analysis of whole cell protein extracts
prepared from strains WE308, WE310, WE312, WE313, WE314 and
WE325 as well as control extracts from a lon+ rcsA+ rcsB- anda
Mon rcsA+ rcsB- strain.No RcsA protein could be detected in any
of the rcsA * mutants.As for the control strains, no RcsA protein
could be detected in either a lon+ rcsB- or a Mon rcsB- strain.This
observation isin agreement with data published by Dierksen, et al.
(22),indicating that no RcsA protein can be detected in rcsB-
strains whether or not Lon protease is present.
rcsAExpressionIsActivatedInThe Presence Of RcsA
Protein
The expression of capsular polysaccharideinE.coli is an
important mechanism for the cell to protect itself from unfavorable
environmentalconditions. Thesynthesisofthecapsular
polysaccharide is an energetically intensive pathway.In order for
a cell to produce the capsule material when conditions warrant its
expression, a complex regulatory network has evolved controlling
the expression of genes whose protein productsare involved in the
synthesisofthecapsularpolysaccharide. Inaddition,the
regulatorscontrollingtheexpressionofthecpsgenes,are93
themselves highlyregulated.Dierksen, et al.,demonstratedthe
absence of RcsA in cells mutant for RcsB and Lon protease.This let
to the hypothesis that rcsA expression might be regulated by other
members of theregulatory network controllingcps expression,
including Lon and RcsA itself.To test this hypothesis, a reporter
gene fusion,consisting of the wild-type rcsAregulatoryregion
fused to a promoterless lacZ gene was used to assess the expression
levels of this fusion in various strain backgrounds.The fusion used
wasobtainedfromDr.DarrenSledjeskiandisdesignated
rcsA90::lacZ. The fusion consists of a 2 kb fragment from pATC352
(116) inserted into the EcoRIISmal sites of the lacZ operon fusion
vector pRS415 (97).The fusion was subsequently crossed onto
bacteriophageXRS45 (97) which was used to lysogenize E.coli
SG20250 resultinginstrain DDS90 (DarrenSledjeski,personal
communication).Strain DDS90 is a partial diploid, carrying a wild-
type copy of the rcsA gene, directing the synthesis of RcsA protein,
as well as the rcsA90::lacZ operon fusion inserted at the Xatt site,
directing the synthesis of 13-galactosidase.Levels of RcsA protein
and levels of13 -galactosidasecanbeassessedfromthesame
sample, by splittingthe sample and using one half to determine
levels of RcsA protein with a Western blot approach and the other
half to determine the activity of the rcsA90::lacZ operon fusion with
a 13-galactosidase enzyme assay.This approach allowed the effects
of a number of individual mutations and combinations of mutations
ontheexpressionlevelof rcsAtobetested, aswellasan
examination of the levels of RcsA protein present in the cells.The94
data collected from these experiments is shown in Figure8.The
top part of the figure represents the 13-galactosidaseactivity of the
rcsA90::lacZ operon fusion from thestrainsassayed,whilethe
picturebelowitrepresentstheresultsfromaWesternblot
approach, detecting the steady state levels of RcsA protein in the
same strains.The bottom part of the figure indicates the relevant
genotype of each strain assayed.Lane1shows the data obtained
for a lon+ rcsA+ rcsB+ rcsA90::lacZstrain.Steady state levels of
RcsA proteinare below detectionlimits,due to Lon dependent
degradation of RcsA, and the activity of the rcsA90::lacZ fusion is
low (14 Miller Units).No RcsA protein can be detected in a lon+
strain carrying a mutation in the wild-type copy of the rcsA gene
(Figure 8, Lane 2).Since this strain carries a null mutation in the
rcsA gene (rcsA::ATn10), no RcsA protein issynthesized and no
RcsA protein is detected.In this strain, the expression level of the
rcsA90::lacZ fusion is similar to that seen
(Figure 8, Lane 1vs. 2).Lane 3 shows the
rcsB+ rcsA90::lacZ strain.In this strain
RcsA proteinishigh(Figure8,Lane
observations that RcsA protein isstabilized
strain background the rcsA90::lacZ fusion is
in a Ion+ rcsA+strain
results for a Alon rcsA+
the steady state level of
3),correlatingtothe
in Alon strains.In this
expressed at a level 100
fold higher (1413 Miller Units) than that seen in the isogenic Ion+
strain (Lane1).Lane 4 represents the results obtained from a
strain which, in addition to a null mutation in Ion, also carries a null
mutation in the rcsA gene (rcsA::ATn10).95
Figure 8.RcsA is involved in regulating its own expression
rcsAexpression was assessedatthetranscriptionallevel
(using a rcsA90::lacZ fusion) and atthe protein level using a
Westernblotapproach.Allstrainsare MC4100 derivatives
carrying a rcsA90::lacZ fusion integrated at the A,att site.
13-galactosidaseassayswerecarriedoutasdescribed by
Miller (74).Cells were grown at 320C in LB broth containing
25pi g/mlkanamycin whereappropriate.Specificactivityis
expressed in Miller units.The values represent the mean of three
assays.
To assess RcsA protein levels, cells were grown toan 0.D.600
of 0.9-1.2 in LB broth containing 25 µg /mlkanamycinwhere
appropriate.For allcultures,1ml aliquots were removed and
preparedforTricine-SDS-polyacrylamidegelelectrophoresis.
Protein concentrations were determined by the bicinchoninic acid
(BCA) protein assay method (Pierce).Equal amounts of protein
(30p, g) from whole cellextracts were boiled in sample buffer,
fractionated on a 14% Tricine-SDS-polyacrylamide gel and analyzed
by Western blot with preabsorbed polyclonal antiserum specificto
E. coli RcsA protein.Immunoreactive proteins were visualized by
enhanced chemiluminescence (ECL).
Lanes: 1, DDS90 (Ion+ rcsA+); 2, JT2057 (lon+ rcsA::41'n10-Kan);
3, JT2046 Won rcsA+); 4, JT2055 Won rcsA::4Tri10-Kan);
5, JT2056 Won rcsitt+ rcsB::4Tn10-Kan).
Genotypes of strains are indicated at the bottom.Symbols
are as follows: +, wild-type gene; -, null mutation in the gene.rcsA::lacZ activity (Miller Units)
12 13141912 12
12345
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80
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Figure8.
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Thisstraindoesnotproduceany RcsA proteinduetothe
transposon insertion in the rcsA ORF and therefore no RcsA protein
is detectable.In this strain, the expression level of the rcsA90::lacZ
fusion drops back to the level seen in a Ion+ rcsA+ rcsB+ rcsA90::lacZ
strain (Lane 1).Finally, Lane 5 depicts the results obtained from a
Mon rcsA+ rcsB+ rcsA90::lacZ strain.In agreement with data
published by Dierksen, et al.(22), no RcsA protein was detectable
in this strain background.In this strain the expression level of the
rcsA90::lacZ fusion is similar to that seen in a lon+ rcsA+ rcsB+
rcsA90::lacZ strain (14 Miller Units).
rcsA Transcription Is Increased In AlonStrains
The activity of the rcsA90::lacZ transcriptionalfusion was
determined in a partial diploid strain carrying the rcsA90::lacZ a s
well as a wild-type rcsA gene.The possibility existed that the
activityof the rcsA90::lacZfusionmeasuredinthisstrain
background did not represent the situation of a strain carrying only
thewild-type rcsA gene.The fusionislocated in a different
context on the E. coli chromosome, so possible effects of other, more
global regulators, might not affect the regulation of the fusion in
the same way asthey would the wild-type gene initsnormal
chromosomal location.In addition, having two identical promoters
in the cell might cause a titration effect, since the same quantity of
regulatoryproteinscouldconceivablybindtotwoidentical98
promoterregions.To addresstheseproblemsaribonuclease
protection assay was carried out to determine the levels of rcsA
mRNA instrains with different genetic backgrounds.A 500 nt
radiolabled antisense rcsA RNA probe was synthesized in vitro as
described in Materials and Methods.This probe was hybridized to
totalcellular RNA isolated from strains SG20250 (lon+ rcsA+ ),
JT4000 Won rcsA+), SG20250 + pATC400 (prcsA+), JT4000 +
pATC400 and WE17 (Mon rcsA::ATn10) and subsequently digested
with an RNAse cocktail consisting of RNase A and RNase T1, which
only degrade single stranded RNA.The 500 nt antisense rcsA
mRNA will hybridize to the rcsA mRNA and protect an rcsA mRNA
fragment of a predicted size of 318 nt from RNAse digestion.After
RNAse digestion,thesamples were analyzed by denaturinggel
electrophoresis ona 5% acrylamide/8 M ureagelfollowed by
audioradiography.Theresultsobtainedfromthisexperiment
paralleltheresultsseen withthe13- g alac to sidaseassaysand
Western blot approach described in Figure 8.The protected piece
of rcsA mRNA was readily detectableina AlonrcsA+strain,
indicatingthat rcsA mRNA is very abundant inthisstrain(data
not shown).rcsA mRNA is not very abundant in a lon+ strain and
could only be detected after prolonged exposure of the film (data
not shown).No rcsA mRNA fragment of the predicted size could be
detectedinstrainswhicharemutantforthercsAa gene
(rcsA::ATn10 ) even after prolonged exposure (data not shown).As
forthepositivecontrols,acorrectsizefragment was readily99
detectedin Alon or Ion+ strainscarryingthe rcsA+plasmid
pATC400 (data not shown)
rcsA90::lacZ Expression Is Regulated By Lon, RcsB and
H-NS
The results presented so far have identified RcsA, Lon and
RcsB as regulators of rcsA expression.In addition, Sledjeski, et al.
identifiedanothernegativeregulatorof rcsAexpression,the
histonelikeprotein H-NS(100).To furtherinvestigatethe
individualroles of these regulators on the expression of rcsA,
expression levels of the rcsA90::lacZ fusion were measured in a
series of rcsA+ strainscarrying mutationsinIon, rcsB and hns
individually or combinations of these genes.The data obtained
from these experiments is summarized in Table 6.In a wild-type
(Ion+ rcsA+ rcsB+ hns+) the expression level of the rcsA90::lacZis
low (27 Miller Units) and no capsuleisproduced (non-mucoid)
(Table 6, Lane 1).In a lon+ strain carrying a mutation in rcsB the
expression level of the rcsA90::lacZ fusion is low and the cells are
non-mucoid (Table6, Lane 2).Expression of the rcsA90::lacZ
increases 10 fold in a hns- strain.This increase isin agreement
with the increase in rcsA expression observed bySledjeski, et al.
(100) in a hns- strain.Even so this strain is lon +, the mutation in
hns and the resulting 10 fold increase in rcsA expression result in
the production of capsule and therefore the mucoid phenotype of
this strain (Table 6, Lane 3).A strain mutant for both rcsBand100
hns expresses the rcsA90::lacZ fusion at a level 10 fold higher than
the lon+ rcsA+ rcsB+ hns+ wild-type strain.The mutation in rcsB
does not impact the expression of the rcsA90::lacZ fusion in a lon+
hns- strain.
Table 6.Effects of mutations in Ion, rcsB and hns on the expression
of the rcsA90::lacZtranscriptional fusion and the production of
capsule.
Relevant genotype fl -galactosidaseactivitya Mucoidb
Ion+ rcsB+ hns+ 2 3
lon+ rcsB- hns+ 2 7
Ion+ rcsB+ hns::ATn10 264
lon+ rcsB- hns::ATn10 242
Alon rcsB+ hns+ 241 5
Alon rcsB- hns+ 2 1
Alon rcsB+ hns::4Tn10 2664
Alon rcsB- hns::ATn10 197
+
+
a p-galactosidase assays were carried out as described by Miller
(74).Numbers represent the average of three independent
assays.
b M ucoidy was assessed visually.
Symbols are as follows: non-mucoid;+ mucoid
This strain however does not produce capsule, presumably due to
the absence of RcsB (11) (Table 6, Line 4).In a strain mutant for
Lon protease,expression of the rcsA90::lacZfusionincreases
dramaticallytoalevelapproximately 100 fold higher than that101
seen in the lon+ rcsA+ rcsB+ hns+ wild-type strain.In a Alon rcsB-
double mutant, the expression of the rcsA90::lacZ fusion drops back
to the level observed in a lon+ rcsB+ strain,consistent withthe
observationsmadebyDierksen, et al.(22)andtheresults
described in Figure 8.This strain does not produce capsule (Table
6, Lane 6).rcsA90::lacZ expression in a Alon hns-rcsB+ double
mutantdoesnotsignificantlyincreasecomparedtoa Alon
rcsB+ hns+ strain (Table 6, Line 7 vs. Line 5).In a Alon rcsB-hns-
triple mutant, expression of the rcsA90::lacZ fusion is increased 10
fold as compared to the isogenic hns+ strain (Table 6, Line 8vs.
Line 6).This strain is non-mucoid.
RcsA Protein Can Be Detected In A Alon resB-11ns- Strain
An increase in rcsA expression appears to parallel an increase
in RcsA stability.To test this hypothesis, steady state levels of
RcsA protein were determined from the same strains described in
Table 6.The results of this experiment are shown in Figure 9.In
the presence of Lon protease, no RcsA protein could be detected,
independent of thestrain's genotype with respect to rcsB or hns
(Figure 9, Lanes 1-4)In the presence of Lon protease RcsA protein
is degraded at such a fast rate that detection with the Western blot
technique employed is not possible.102
Figure 9.Detection of RcsA in lon-, rcs13-, hns- strains.
To assess RcsA protein levels cells were grown to an 0.D.600 of
0.9-1.2 in LB broth containing 25 lig/m1 kanamycin and 25 [tg/m1
tetracycline where appropriate.For all cultures,1 ml aliquots were
removedandpreparedforTricine-SDS-polyacrylamidegel
electrophoresis.Proteinconcentrations were determined bythe
Bicinchoninic acid (BCA) protein assay method (Pierce).Equal
amounts of protein (30 p.g) from whole cell extracts were boiled in
sample buffer,fractionated on a 14% Tricine-SDS-polyacrylamide
geland analyzed by Western blot with preabsorbed polyclonal
antiserum specific to E. coli RcsA protein.Immunoreactive proteins
were visualized by enhanced chemiluminescence (ECL).
Lanes: 1, DDS90 (Ion+ rcsA+ rcsB+); 2, JT2046 (Won rcsA+ rcsB+);
3, JT2058 (Ion+ rcsA+ rcsB::ATn10-Kan);
4, JT2056 (Alon rcsA+ rcsB::ATn10-Kan);
5, WE28 (lon+ rcsA+ rcsB+ hns::ATn/O-Tet);
6, WE29 (Alon rcsA+ rcsB+ hns:ATn/O-Tet);
7, WE30 (Ion+ rcsA+ rcsB::ATn/O-Kan hns::ATn/O-Tet);
8, WE31 (Alon rcsA+ rcsB::ATn10-Kan hns::ATn10-Tet).
All strains are MC4100 derivatives carrying a rcsA90::lacZ
fusionintegratedatthe katt site.Genotypesofstrainsare
indicated at the bottom.
Symbols are as follows: +, wild-type gene;-, null mutation in
the gene.ion
rcsB
has
Figure9.
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Even instrainswitha10foldhigher expressionlevelof the
rcsA90::lacZfusion and a mucoid phenotype (lon+ rcsB+ hns-
rcsA90::lacZ or lon+ rcsB- hns-rcsA90::lacZ ) was detection of steady
state levels of RcsA protein not possible (Figure 9, Lines 3 and 4).
In the absence of Lon protease (dlon), RcsA is stabilized and readily
detectable with the Western blot approach utilized (Figure 9, Lane
5).The drop in rcsA90::lacZ expression levels seen in a Mon rcsB-
hns+ rcsA90::lacZ strain (Table 6, Line 6)tolevels seen ina
lon+ rcsB+hns+strain,isparalleled by thedisappearance of
detectable levels of RcsA protein in a Mon rcsB- hns+ rcsA90::lacZ
strain (Figure 9, Lane 6).The absence of RcsB has a negative effect
on the expression of rcsA, and this effectis independent of Lon
protease, since RcsA protein is undetectable in rcsB- cells,whether
or not they are lon+ or dlon.The introduction of a mutation in the
gene coding for the negative regulator of rcsA expression, hns,
increases the expression of rcsA 10 fold, however this increase is
not sufficientto allow for the detection of RcsA protein inthe
presence of Lon protease.In Mon rcsB+ cells introductionof a
mutation in hns has no effect on the levels of detectable RcsA
protein.The quantities of RcsA in dlon rcsB+ hns+ cells are already
very high, so that an increase in these quantities would probably
not be detectablewiththeassay employed inthisexperiment
(Figure 9, Lane 7).Introduction of a mutation in hns, however has
a dramatic effect on expression levels of the rcsA90::lacZfusion
(Table 6, Line 8) as well as on the steady state levels of RcsA
protein in a Mon rcsB-strain (Figure 9, Lane 8).The negative105
effects of the absence of RcsB on rcsA expressionarepartially
offset by the positive effect the absence of H-NS has on rcsA
expression and steadystatelevelsof RcsA proteinarereadily
detectable in thisstrain.The levels of RcsA detected are clearly
lower than those seen in a Alon rcsB+ strain (Figure9, Lane 5),
which corresponds well with the observation that expression levels
of the rcsA90::lacZ fusion in this strain background is 10 fold above
wild-type level (lon+ rcs13+ hns+) but still 10 fold below the level
seen in a Alon rcsB+hns+ strain.
rcsA Expression Is Increased In lon+rcsA* Strains
Expression of the rcsA90::lacZtranscriptionalfusionis
increased approximately 100 fold in a Mon strain as compared to a
lon+ strain.As indicated earlier, this increase is apparently due to
a positive effect of RcsA on the expression of its own structural
geneThe increase in rcsA expression is not a direct effect of the
absence of Lon protease (i.e. Lon does not function as a repressor of
rcsA expression),since the effect of a mutation inion canbe
abolished by a mutation in rcsA.Since the increase of expression
in rcsA is dependent on the presence of RcsA protein in the cell, we
hypothesizedthatrcsA expression instrainscarrying the rcsA *
alleles discussed earlier would be increased, due to the increased
stabilityof thealtered RcsA proteins.The results from these
experiments are shown in Table 7.Both rcsA *mutants show a106
dramatic increase in the levels of rcsA90::lacZ expression in a lon+
strain (35 fold) compared to the wild-type lon+ rcsA+ strain (Table
7, Lines1vs. Line 3 and 5) consistent with the hypothesis that
rcsA expression is increased in strains with stabilized RcsA protein.
rcsA90::lacZ activity increased about 20 fold in a Alon rcsA+ strain
compared to the lon+ rcsA+ strain (Table 7, Line 2 vs. Line 1) and
the activity of the rcsA90::lacZ fusion was increased by another
approximately1.5fold in Mon rcsA* strains as compared to the
Alon rcsA+ control (Table 7, Lines 4 and 6).
Table 7.rcsA expression is increased in lon+ rcsA* strains.
Relevant genotype rcsA90::lacZ fold increase
0-galactosidaseactivityaover wild-type
lon+ rcsA+
lon::AlCan rcsA+
lon+ rcsA*112
lon::AKan rcsA*112
lon+ rcsA*125
/on::AKan rcsA*125
17
397 20
604 3 6
872 5 1
570 34
7 1 6 42
a Vgalactosidase assays were carried out as described by Miller
(74).Numbers represent the average of three independent
assays.107
Identification Of A Putative "RcsA-Box"
The dataobtained fromtheexperimentsdescribed above
indicates the possible involvement of RcsA protein in regulating its
own expression.Previous work by Stout, et al.(109)identified
RcsA as a positive activator of cps gene expression.If RcsA acts as
atranscriptionalactivator of both cpsand rcsAexpression,by
specifically interacting with the promoter regions of these genes, a
sequence motif might be identified which representsthesiteof
RcsA binding.Alignment of the region upstream of the rcsA
transcriptionalstartsite(100)(Figure10a)andtheregion
upstream of the cps transcriptionalstartsite (106) (Figure 10 b)
using the "bestfit" program within the GCG package (20) identified
a 25 by region of 80% identity between the rcsA and cps promoter
regions which was termed "RcsABox" (Figure 10 c).The putative
"RcsA-Box" is very AT rich (80%) and the 13 bases at the 3' end of
the box constitute a perfect (for cps) and nearly perfect (for rcsA)
inverted repeat (CTTAAT-A-TAATTC).The "RcsA-Box" is located
30 by upstream fromthe-35signalofthecpspromoter
(Figure 10 a) and 117 by upstream from the -35 signal of the rcsA
promoter (Figure 10 b).108
Figure 10.Identification of a putative "RcsA-Box"
a) rcsAand b) cps promoterregions;-10,-35region,
transcriptionalstartsite(+1)andputative"RcsA-Box"arein
boldface c)"bestfit" alignment of cps and rcsA promoter region,
putative "RcsA-Box" in boldface.109
a) cps promoter region
-119 GTCAACCTAA
"RcsA-Box"
79 CTTAATATAA
-35
- 39 ATCTTGCCTG
I-putative
AGAAACTCCT AAAAACCATA TTGAATGACA
TTCTTAAAAA TAGCCAATTA CCGAATTGTT
-10 +1
CTATTCCGTT AGCTGTAACA CTTCCTCCTG
+2 CATTATTGGA AAGCCAATAT TCAATTACCA +31
b) rcsA promoter region
I-putative"RcsA-Box"
200 AATTTGCTGG CTGATATTAT TAGTGAATTG CCATTAATAT
160 AATTCCGTAA CGTTTATCAT GTTATCCTAA GGATTATCCG
120 AAAAATAATA CCTACGAACA TCTTCCAGGA TACTCCTGCA
80 GCGAAATATT TGTTTTAAGC TCACTCACAT ATCGCAACAT
-35 -10 +1
40 TTACTTTACT TTAAGACAAT TCCAGGCAAA TTATACAACA
+2 CTTTACGGGA TAGTAAGTCC GCCTGAAAAA +31
c) GCG "Bestfit" alignment of cps and rcsA promoter regions
cps
iiiiiiiiiiii
ttaaa
rcsAat tatTAGTGAATTGCCATTAATATAATTCcgtaa
"RcsA-Box"
Figure 10.110
Effects Of The "RcsA-Box" On Expression Of rcsA And cps
To assesstheeffectsof theputative "RcsA-Box" on the
expression of rcsA and cps, a series of strains containing operon
fusions of the rcsA or cps promoter regions with, or without the
putative "RcsA-Box" to a promoterless lacZ gene was constructed as
described in Materials and Methods.A prediction can be made,
that, if the putative "RcsA-Box" is the site of RcsA binding to the
promoter regions of rcsA and cps, the respective constructs lacking
the putative "RcsA-Box" should not respond to a mutation in Ion,
since stabilized RcsA would not have a site to bind to in front of the
rcsA or cps promoter.Incontrast,theconstructs containing the
putative "RcsA-Box" should respond toa mutation in ion, since
stabilized RcsA can bind to the putative "RcsA-Box" and activate
rcsA or cps expression.13-galactosidase assays were carried out for
all promoter fusion constructs in strains carrying mutations in Ion,
rcsA and rcsB and combinations of these mutations.The results for
these experiments are shown in Table 8.As observed before, in a
lon+ strain the expression level of the rcsA90::lacZ fusion is low
(Table 8, Column 2, Lane 1).Introduction of mutations in rcsA,
rcsB or rcsA and rcsBdoesnotaffecttheexpressionofthe
rcsA90::lacZ fusion (Table 8, Column 2, Lane 2-4). A mutation in Ion
increases the expression level of the rcsA90::lacZ fusion 100 fold
(Table 8, Column 2, Lane 5).Table 8.Effect of the putative "RcsA-box" on the expression of rcsA::lacZ and cps::lacZoperon fusions.
-galactosidaseactivitya
Relevant genotype rcsA90::lacZ b rcsA 09: :lacZ C cps1o3::lacZ b cps41::lacZ
Ion+ rcsA+ rcsB+ 1 2 4 0 4 7 1 7
Ion+ rcsii- rcsB+ 1 3 3 4 0 7 1 3
Ion+ rcsA+ rcsB- 1 2 4 5 5 1 1 9
Ion+ rcsli- rcs13- 2 4 3 2 4 9 1 4
Mon rcsA+ rcsB+ 1 4 1 9 3 7 8 1 3 9 2 0
dlon rcsA- rcsB+ 1 2 41 3 6 8
Mon rcsA+ rcsB- 1 2 3 7 4 3 8
Mon rcsA- rcsB- 29 337 12 24
a 13 -galactosidaseassays were carried out as described by Miller (74).
Numbers represent the average of three independent assays.
b these fusions contain the putative "RcsA-Box", for strainnames see Table 2.
These fusions do not contain the putative "RcsA-Box", for strain namessee Table 2.1 1 2
As seen before, the introduction of mutations in rcsA, rcsB, or rcsA
and rcsB return the activity of the rcsA90::lacZ fusion back to the
level seen ina Ion+strain(Table8,Column2,Lane6-8).
Expression of the shorter rcsAi09::lacZ fusion missing the putative
"RcsA-Box" issubstantially higher in a Ion+strain (40 fold) than
that of the rcsA90::lacZ fusion in a lon+ strain (Table 8, Column 2
and 3, Lane 1)Baseline expression of the rcsAi09::lacZ fusion is
high due to the absence of the silencing effect of H-NS seen with
the longer fusion.The rcsA 1 09::/acZfusions does not respond to a
mutation in has (data not shown).The high baseline expression
level for this fusion corresponds to the levels seen in other short
rcsA::lacZ fusions which are non responsive to H-NS silencing (100).
Since the rcsAi09::lacZ fusion is not silenced by H-NS the actual
expression levels of this fusion should not be compared directly to
the expression levels of the H-NS silenced rcsA90::lacZ fusion.
However, the trends seen within each fusionin response tothe
introduction of various mutations are comparable.Introduction of
mutations in Ion, rcsA, rcsB or combinations of these mutations
does not change the expression level of the rcsA109::lacZ (Table8,
Columns 3, Lines 2-8).Baseline expression of the cps] 03::/acZ and
cps41::lacZ is low in a Ion+ strain (Table 8, Columns 4 and 5, Line 1).
The level seen with both these fusions is similar to that seen with
other wild-type cps fusions (i.e. cpsB10::lacZ).Mutations in rcsA,
rcsB or both rcsA and rcsB do not change the expression level of
eitherfusion(Table8,Columns 4 and5,Lines2-4).This
observation isin agreement with the model for the regulation of1 1 3
cps expression, since both RcsA and RcsB are required for optimal
cpsexpression.The introduction of a mutation in ion leads to a 20
fold increase in cpsio3::lacZ expression (Table 8, Column 4, Line 5),
while the expression level of the cps41::lacZfusion does not change
in response to a stabilization of RcsA (Table 8, Column 5, Line 5).
Expression levels of both fusions return to the baseline levels seen
in the wild-type strains with the introduction of mutations in rcsA,
rcsB or rcsA and rcsB (Table 8, Columns 4 and 5, Lines 6-8).1 1 4
Discussionand Summary
Lon Recognizes Su1A With A Higher Affinity Than RcsA
Energydependentproteaseshavegainedtremendous
amounts of interest in recent years due totheir ubiquitous nature
and the importance of the pathways they regulate.E.coli Lon
proteaseisthebeststudiedof thebacterialenergy dependent
proteases,buttheunderstanding ofitsmechanism of substrate
recognition isstill unclear.
Dervyn,et al.observed that saturation of Lon protease with
one of itssubstrates, SulA, protects other substrates such as RcsA
and the abnormal protein, XOts, from Lon dependent degradation as
evident bythe mucoid phenotype of thesestrains(19).This
observation allowed them to generate mutant Su1A proteins which
were biologically active, but had lost their ability to saturate Lon
protease (19).All mutants characterized in Dervyn's study (those
that could no longer protect RcsA from Lon dependent degradation)
werestilldegradedina Lon dependent fashionbut withan
extended half-life.Additionally,the mutant Su1A proteinsstill
protected XOts from degradation.The authors concluded from these
findings that Lon protease has two binding sites, a high affinity site
for specific substrates such as Su1A and RcsA, and a low affinity
site for non specific, abnormal proteins such as XO ts.Presumably,
mutations in SulA which impair itsability to saturate Lon protease
changed Su1A fromahighaffinitysubstratetoa lowaffinity1 1 5
substrate no longer ableto compete with RcsA and therefore no
longer able to protect RcsA from Lon dependent degradation (19).
The results presented inthisdissertation support Huisman's
hypothesisthatspecificLonsubstratescompeteforthesame
binding site, however, it appears that specific substrates have very
different affinities for the protease.lon+ cells overexpressing RcsA
from a multicopy plasmid are mucoid due tothe stabilization of
RcsA, but these cells arestillresistant to DNA damaging agents,
indicatingthat RcsA cannot protect Su1A from Lon dependent
degradation.In thissituation RcsA issynthesized at levels high
enough to realize its biological activity asit eludes Lon dependent
degradation.
GottesmanandcoworkershavehypothesizedthatRcsA
aggregatesunderthesecircumstancesandthusisnolonger
available to Lon protease for degradation (60).However, sufficient
RcsA protein must be in a functional state to interact with RcsB
leading totheactivation of cps expression,sincethecellsare
mucoid.In addition, the amount of non aggregated, functional RcsA
must besufficientto overcome Lon dependent degradation and
persist in the cells long enough to activate cps expression.Under
these conditions the half-life of RcsA proteinisestimated to be
approximately 5 min., indicating that the protein is not stable, but
rather the rate of synthesis exceeds the rate of degradation.
The observationthat RcsA cannot protect Su1A from Lon
dependent degradation indicates that Su1A has a higher affinity for
Lonprotease,sinceunderconditionswhere Lon proteaseis1 1 6
saturatedwith RcsA,theinductionof sulA does not leadto
filamentation and cell death as seen in a Alon strain.E. coli lon+
cells overexpressing RcsA appear phenotypically lon- with respect
tothe mucoid phenotype, but appear phenotypically Ion+with
respect totheir sensitivityto DNA damaging agents, while Ion+
strainsoverexpressingSulAappearphenotypicallylon- with
respect tothe "RcsA" (mucoid) phenotypes.What could be the
significance of Lon's different affinities for its substrates?
Accumulation of RcsA induces the expression of the cps genes
leading to the production of colanic acid, a metabolically intensive
but non-lethal consequence, while accumulation of SulA on the
other hand induceslethalfilamentation.Another Lon substrate,
CcdA, has been shown to have a low affinity for Lon (124).In light
of CcdA's function, namely to neutralize the toxin CcdB, this makes
biological sense. The function of CcdA and CcdB serve to ensure the
stability of the F plasmid upon cell division.If a cell has lost the
plasmid, the unstable antidote protein CcdA is degraded and cannot
bereplenished,whilethestabletoxin CcdB can carryoutits
function once CcdA is degraded.If CcdA's affinity for Lon was high,
then the possibility would exists that CcdA is degraded too rapidly,
for example under heat shock conditions when synthesis of Lon is
increased, possibly leading to the killing of plasmid carrying cells.
Thesefindings seemtoindicatethattheaffinityof the
different Lon substratesinE.coliisdependent on the function
these proteins carry out inthecell.The observation that RcsA
cannotprotect SulA from Lon dependent degradationsuggests1 1 7
substrate binding of specific substrates occurs at the same site, but
differentsubstrateshavedifferentaffinitiesfortheprotease.
These findingsaresupported by data generated by Trempy and
coworkers, demonstrating that mutationsinion can be identified
which give riseto a Lon proteasestillable to degrade SuIA, but
unable to degrade RcsA (Ebel, W., Dierksen, K.P. and Trempy, J.E.
1997, manuscript inpreparation).
The observationthatE.coli Lonproteasecanpartially
complement the defects resulting from a mutation in the LONgene
of S.cerevisiae and that the Ion gene from A.brasilense and E.
amylovora can complement phenotypes resulting from a mutation
in the E. coli ion gene indicate that Lon protease has a conserved
mechanism of substrate recognition.The observation that different
Lon substrates haveadifferentaffinityfortheprotease might
indicatethatthefeaturerecognizedbytheproteaseisless
conserved insubstrates with a lower affinity and therefore these
substrates cannot prevent degradation of higher affinitysubstrates,
such as Su1A, which may have a more highlyconserved substrate
recognitionsite.
A Single Copy Approach, Targeted Mutagenesis, Allows For
TheIdentificationOf RcsAProteinResistantToLon
DependentDegradation.
Overexpressionofproteinsinanycellcreatesanon-
physiological situation.Under these circumstances the response of1 1 8
thesecells may bedifferent than that whichisobserved under
normalconditions.Thus,saturationstudies would notbean
appropriate approach for the identification of substrate recognition
sites.As defined by saturation studies, Su1A would appear to be
thepreferredcandidatefortheidentificationofsubstrate
recognitionsites.However, mutant SulA proteins which are no
longer degraded by Lon protease are not easily identifiable for two
possible reasons:1) mutant SulA proteins are recognized by Lon or
other proteasesasabnormal proteinsandarethereforerapidly
degraded, or 2) expression of mutant Su1A protein which istruly
stable islethal, and thus cells expressing such a protein cannot be
rescued.
Inlightof thebiological impact realized withstabilizing
lethal, yet highly preferred substrates such as Su1A, RcsA becomes
the preferred substrate for defining recognition sites.Therefore a
single copy approach was applied toidentify mutations in rcsA
(rcsA *) which give rise to mutant RcsA protein (RcsA*) resistant to
Lon dependent degradation.This approach has the advantages that
thecells express physiological levels of thesubstrate and large
numbers of mutants can be screened rapidly.
In the case of rcsAthescreening of mutants generated by
this approach is carried out on the basis of their capsule phenotype:
lon+cells expressing wild-type RcsA protein are non-mucoid, since
RcsA is rapidly degraded in a Lon dependent fashion.If a mutation
in rcsA can be isolated which gives rise to RcsA resistant to Lon1 1 9
dependent degradation, these cells would appear mucoid due to the
stabilization of RcsA.
The targeted mutagenesis of rcsA yielded 30 mutant strains
which expressed the cps genesatlevels well above background.
The expression levels of the cps genes in these strains ranged from
10 fold to more than 200 fold above wild-type activity.Several
predictions can be made to explain this range of cpsexpression.
Expression of rcsA from a multicopy plasmid in lon+ cells leads to
the expression of capsule at high levels, indicating that increased
production of RcsA can mimicasituationin which RcsAis
stabilized.
Similarly,Sledjeski and Gottesman have shown thatinthe
absence of H-NS, rcsA expression is increased 10 fold, leading to
the expression of capsule in lon+ cells (100).In both cases rcsA
expressionisincreasedtoapoint where therateof synthesis
exceeds the rate of degradation, but RcsA is not truly stable, since
itisstill degraded rapidly in a Lon dependent fashion.In strains
mutant for hns, no steady state levels of RcsA are detectable even
though cellsare mucoidThis indicates that rcsA expressionis
increased to a point where RcsA persists long enough to activate
capsule gene expression but levels of RcsA remain below detection
limits.
Likewise,promoter mutationswouldresultinasimilar
phenotype, thusthepossibilityexiststhatseveral of the rcsA *
mutations isolatedinthetargeted mutagenesis approach do not
represent mutations inthestructural gene of rcsA but represent120
mutationsinrcsA'sregulatoryregionwhichincreasercsA
expression.The regulation of rcsA expression has not been studied
in detail, and beyond the silencing effect of H-NS, nothing is known
aboutotherpossibleregulatory mechanisms. Promoter mutants,
even thoughthey would notaidintheunderstandingofthe
substrate recognition mechanism of Lon protease,are of interest,
sincethey might helpdefinethe mechanisms governing rcsA
expression.
Of the 30 rcsA * mutants identified based on their ability to
express the cpsgenes in the presence of Lon protease, 16 did not
have detectable steady state levels of RcsA protein.15 of the 16
mutants that fall into this category express the cps genes at levels
less than 100 fold higher than wild-type strains.The observation
that more than 50% of the rcsA* mutants isolated express the cps
genesat elevated levels but do not have detectable steady state
levels of RcsA protein seems to indicate that the regulation of rcsA
expressionishighlysusceptibletomutationswhichleadto
increased rcsA expression.Sledjeski, et al. identified a small stable
RNA, DsrA, as a regulator of rcsA expression.If overproduced,
DsrA interferes with the ability of H-NS to silence rcsA expression
(100).The gene encoding DsrA is located immediately downstream
of rcsA (100), and the possibility existsthat mutations leading to
increased DsrA levels were isolated in this screen.
The remaining 14 rcsA *mutantsallhad detectable steady
statelevels of RcsA* protein, but only six of these mutants had
detectable protein levels for more than1minute.Of thesesix1 2 1
mutants, five (WE108, WE110, WE113, WE114 and WE125) showed
RcsA levels decreasing during the course of the experiment with
complete degradation of the protein between 15 and 30 minutes.
WE112 was the only mutant identified inthis experiment which
expressed truly stable RcsA protein.The RcsA* protein expressed
by this mutant is not degraded by Lon protease and persists in the
cells.The half-lives determined for the RcsA* proteins ranges
from approximately1minutefor WE108, WE110, WE113 and
WE114 to approximately 5 min for WE125. A true half-life for the
RcsA* protein from WE112 cannot be estimated since the quantity
of RcsA protein does not diminish over time.
Sequencing of the mutant allelesidentified changes inthe
open reading frame of WE112 and WE125 which lead tosingle
amino acid substitutions.WE112 has a change of amino acid 145
from methionine toisoleucine.A similar mutant (M145V) was
identified by Gottesman and coworkers (109)usingadifferent
mutagenesis approach (mutD) (50).The change from methionine to
valine increased the half-life of the RcsA protein to an estimated 3
min. (109).In contrast, a mutation from methionine to isoleucine
atthe same position leadsto complete stabilization of the RcsA
protein.Stout, et al.usedapulse/chase approach followed by
immunoprecipitation to determine the half-life of the RcsA protein,
while in the studies presented here, protein synthesis was arrested
by the addition of Spectinomycin (33), followed by Western blot
detection of RcsA protein.Even though the two experimental
approaches are different, and a direct comparison of the data is not1 2 2
possible,thedramaticdifferenceinthehalf-lifeofthetwo
differentmutantscannot beattributedsolelytothedifferent
procedures.Stout, et al.identified a region near methionine 145 as
RcsA's putative DNA binding domain based on thesimilarity of
amino acids156 to172tothe conserved helix-turn-helix motif
implicatedin DNA binding(80).The putativehelix-turn-helix
motif isnot particularly highly conserved, and depending on the
sequence analysis program used to predict the secondary structure
of the protein, the region is not always identified as helical.For
example, analysis of the RcsA primary amino acid sequence using a
secondary structure prediction program provided by Burkhard Rost
at the EMBL in Heidelberg, Germany (88, 89) does not identify this
region as one adopting helical structure.Therefore the importance
ofthisareaastheregionof DNA bindingremainstobe
demonstrated.
Methionine 145 lies in a region rich in methionine: of the 9
methionine residues found in RcsA, 5 are within a 30 amino acid
stretch(133-162).The arrangementofthesemethioninesis
symmetric: M M XX M X M X(i M (with X any amino acid).
This patternof methioninesisconservedinthe RcsA proteins
identified in Klebsiellaaerogenes, Erwinia amylovora and Erwinia
stewartii(1,6,84).A similarlysymmetric arrangement of
methionine residues cannot be found in either SuIA, CcdA or XN
protein.However, the area of CcdA whichishypothesized to
interact with CcdB to protect CcdA from Lon dependent degradation
is also relatively rich in methionine (3 of the 4 methionine residues1 2 3
of CcdA) and one of these methionines was identified as the site of
cleavage (124).
Thisareaof RcsA hasbeenimplicatedinRcsA/RcsB
interactionandStout, et al.hypothesizedthatthechangeof
methionine145tovaline would increasethestabilityofthis
interaction,since overproduction of RcsB extended the observed
half-lifeof their RcsA* mutant protein(109).Inlight of the
conservationofthisregionbetweentheRcsAproteinfrom
different species,it seems unlikely that,if this area is involved in
theinteractionof RcsA with RcsB,achange away fromthe
consensus would increasethestabilityof thisinteraction.The
observation that RcsA* persistslightly longer inthe presence of
multicopy RcsB must haveadifferentexplanation(seelater).
Methionine 145liesina region predicted to adopt a a -he li c al
secondarystructure,and the change of methionine toisoleucine
does not eliminate this predicted helicalstructure.Therefore,if
this structure is important for the function of RcsA, the change of
methionine 145 to isoleucinedoes not appear to alter the overall
structure of this region.
Mutant WE125 has a single amino acid change at position 181
from lysine to glutamine.The mutant protein has a half-life of
approximately 5 minutes, well above the predicted1minute half-
life of wild-type RcsA (109).Lysine 181is the last residue of a
predictedhelicalsegment of RcsA,thechange fromlysineto
glutamine replaces a charged, polar amino acid with a non-charged
polar amino acid.The area around lysine 181 is rich in basic amino124
acids, particularly lysine.Nine of 21 residues inthisstretch are
lysine,of the remaining12, 4 more are basic.Recent data by
Trempy and coworkers (Ebel, W., Dierksen, K.P. and Trempy, J.E., in
preparation) implicatesa region of Lon protease made up of a
stretch of basic amino acids, followed by a stretch of acidic amino
acids and a stretch of basic amino acids in substrate binding.The
possibilityexists,thatthearea around lysine181interacts with
this domain of Lon.Poetter and Cop lin (84) identified this region,
including lysine181,asa putativehelix-turn-helix motif.The
sequence shows more similarity to the consensus for this structural
motif than the sequence predicted by Stout, et al.to constitute a
helix-turn-helix motif (109).The region including both methionine
145 and lysine181ishighly conserved between the four RcsA
isolates and appears to constitute a region of importance for RcsA
function.As with WE112, the mutation identified in WE125 does
not alter the predicted secondary structure of RcsA in this region,
as assessed by comparison of the predicted secondary structure for
the wild-type RcsA protein and the two mutant RcsA* proteins.
Disruption of secondary structure motifs which are important for
RcsA functionwould not have beenidentifiedinthescreen
employed, since the mutants were identified based on their ability
to activate capsule gene expression in the presence of Lon.The
changes introduced into RcsA at position 145 and 181fall into the
C-terminal region of the protein, which has been implicated in both
DNA binding and in the interaction of RcsA with RcsB (109).This
region appears as the most important region for RcsA activity and1 2 5
for its interaction with RcsB and Lon, since all mutations identified
which increase RcsA stabilityfallintothis region.The changes
introducedinto RcsAatposition145or181mightalterthe
structure of RcsA sufficiently to prevent or weaken RcsA binding
byLon. Thesaturationstudiesdiscussedearlierhave
demonstrated that Lon's affinity for RcsA is lower than itsaffinity
for Su1A.This observation seems to indicate that the recognition
site for Lon is not very highly conserved in RcsA and slight changes
inthestructure of RcsA might changeitsufficientlyto prevent
recognition by Lon.
Sequencing of WE108, WE110, WE113 and WE114 did not
identify any changes inthe rcsA open reading frame.Since an
increase in RcsA synthesis can lead to detectable levels of RcsA in a
lon+ cell, the putative promoter region (100) of these alleles as well
as the promoter region of WE112 and WE125 was sequenced.No
changes in the promoter regions of WE108, WE110, WE112 and
WE125 were identified.For both WE113 and WE114 asingle
nucleotide change was detectedat position -17 from cytosineto
thymine.This position resides in-between the putative -10 and
-35 regions of the rcsA promoter (100).The change from C to T at
this position seems sufficient to increase rcsA expression tolevels
high enough to detect RcsA in the presence of Lon protease and to
activate cps expression.Sledjeski, et al.identified a single base
change in the rcsA promoter region which changed this promoter
from one thatis nonresponsive to H-NS silencing to one thatis
responsiveto H-NS silencing,similartothe wild-type promoter126
(100).The fact that a single base change has such a dramatic effect
with regard to H-NS silencing is a good indication that the change
observed at position -17 in WE113 and WE114 is indeed a true
promoter up mutation which either allowsfora more efficient
binding of a possible activator of RcsA expression or the change
might prevent the binding of a putative repressor.The half-life of
the RcsA protein synthesized by these mutants was determined to
be approximately1minute.This half-life is in agreement with the
previously estimated half-life of RcsA expressed from a single copy
rcsA gene.The change seen in WE113/WE114 does not interfere
with H-NS binding, since no RcsA protein can be detected in a lon+
strain in the absence of H-NS.The absence of H-NS causes an
approximately10 fold increasein rcsAexpressionresultingin
mucoid colonies but no detectable levels of RcsA protein.RcsA
proteinisreadily detectable in WE113/WE114 indicating that the
change introduced in these mutants interferes with another aspect
of rcsA regulation whichisasof yet unknown.No sequence
changes could be identified in the promoter region of either WE108
and WE110.Several possibilities exist to explain the behavior of
mutants WE108 and WE110 inthe absence of mutations inthe
open reading frame.The promoter region sequenced extended
through position-109,assumingthatmutationsin WE108 and
WE110 were introducedinthearea upstream of position -109
seems to indicate that the area upstream of the identified promoter
region is important in the regulation of rcsA expression.Or, up
mutations might have been introduced into the promoter region of127
the dsrAgene,locatedimmediatelydownstreamofrcsA.
Mutations leading to increased expression of dsrAincrease rcsA
expression, due tothe interference of DsrA with H-NS' abilityto
silence gene expression, and cells appear mucoid.
Gottesmanandcoworkershypothesizedthatthechange
identified in their rcsA * mutant did not eliminate the recognition of
RcsA by Lon, but rather stabilized the interaction of RcsA with its
partner RcsB (109).This interaction has not been demonstrated in
vitro;theevidenceforthisinteractionhas been derived from
genetic studies (109).The Lon substrates CcdA and Su1Aare
protected by theinteraction withtheir partnersin vivo (14,59,
123).Stout, et al.demonstratedthatinstrainsoverexpressing
RcsB,theirRcsA*mutantproteincouldbedetectedwhen
synthesizedonly fromachromosomal copy of thegene.In
contrast, they noted, that in a strain which expresses RcsB from a
single copy, RcsA* synthesized from a single copy of the gene was
notdetectable(109).To addressthequestionifthe changes
introduced in RcsA which leadto an increase in RcsA half-life are
due to a more stable interaction of RcsA with RcsB, we attempted to
determine the half-lives of the RcsA* proteins in a lon+ rcsB- strain;
no RcsA* could bedetectedintheabsence of RcsB protein.
Additionally, RcsA protein could not be detected in lon+ rcsB- and
Alon rcsB- cells.This observation isin agreement with work by
Dierksen, et al. who demonstrated for the first time that RcsA could
not be detected in d lonrcsB-cells(22).RcsB has not been
implicated inthe regulation of rcsA expression, and no data is1 2 8
available on the levels of the RcsA* protein identified by Stout, et
al. in a A IonrcsB- strain.Dierksen, et al.demonstratedthat
expression of rcsA does not require the presence of RcsB, since in a
rcsB- strain RcsA can be detectedif rcsAisexpressed froma
multicopy plasmid (22).If the expression of a single copy rcsA
gene in a Alon straindepends onthepresenceof RcsB,the
observation that an RcsA* protein, which is stable in a lon+ rcsB+
strain,is not detected in a AlonrcsB-strain,cannot simply be
explained with a stabilized RcsA/RcsB interaction.Since wild-type
RcsA cannot be detected in a Mon rcsB- or a lon+ rcsB- strain, the
reason for not detecting RcsA* in a lon+ rcsB- strain might simply
be due to the fact that RcsA* protein was never made in the first
place. If rcsA* could be expressed in the absence of RcsB, the true
stability of the RcsA* proteins in the presence of Lon could be
assessed.Alternatively, the absence of RcsB could expose RcsA to
other proteases which degrade RcsA in the absence of Lon.In a
Alon strain, the half-life of RcsA is only increased to approximately
30 minutes, which does not constitute stability (63, 109, 117, 118).
rcsA Expression Is Regulated By RcsA Protein
The observation that RcsA could not be detected in a Mon
rcsB- strainraisedthequestionof how rcsAexpressionis
regulated.Sledjeski, et al.demonstrated that rcsA expressionis
silencedby H-NS(100)ahistone-likeproteinimplicatedin
regulating a large number of unrelated genes(4,121).Beyond129
H-NSsilencing and the effect of RcsB, no information on the
mechanisms governing rcsA expression is known.In the course of
these studiesit was noted that the expression of the rcsA90::lacZ
transcriptional fusion used to assess the levels of rcsAexpression
was dramatically increased instrains carrying a mutation in Ion.
The strain used for these studies is a derivative of DDS90, a strain
carrying the wild-type rcsA gene in addition to the rcsA90::lacZ
transcriptional fusion located at the Xatt site.This strain is diploid
with respect to the rcsA promoter, one promoter regulateswild-
type rcsA gene expression and thus controls expression of RcsA
protein, while the second promoter regulates lacZ gene expression
and thus levels of (3-galactosidaseinthisstrainare representative
of rcsA promoter activity.What might account for the increased
rcsA90::lacZexpression in ion- derivatives of this diploid strain?In
the absence of Lon protease, RcsA protein is stabilized, as reflected
bythe mucoid phenotype of ion-cells.If expression of the
rcsA90::lacZ fusion is increased in a ion' strain,then a prediction
can be made,thatthestabilized RcsA proteinisinvolvedin
activating its own expression.Assessing the levels of rcsA90::lacZ
expression in a Mon rcsA-strain support this hypothesis:in the
absence of Lon and a functional RcsA gene, theactivity of the
rcsA90::lacZ fusion is low.In contrast, if RcsA is produced from a
multicopy plasmid in the presence of Lon, the level of rcsA90::lacZ
expression increases (data not shown).The increased expression of
the rcsA90::lacZ fusion is paralleled at the protein level.If both
regulators, H-NS and Lon are removed, one might expectthe1 3 0
expression of rcsAtoincreasecontinuously,sinceallapparent
regulatory mechanisms are removed.However, rcsA expression in
a Alon hns- strain does not increase beyond approximately 100 fold
abovewild-typelevels. Whatfactorsmightexplainthis
observation?If RcsA is involved in activating its own expression, a
mechanism might exist to limit rcsA expression, thus providing the
means tolimit expression of rcsAtolevels adequate under the
given circumstances.As mentioned before,the half-life of wild-
type RcsA protein in ion- cells was determined to be approximately
30 minutes, indicating that RcsA is not completely stable even in
theabsence of Lon,indicatingthatalternativeproteasesexists
which can degrade RcsA in the absence of Lon (63, 117, 118).This
Lon independent degradation of RcsA may constitute the limiting
factor in the self activation of RcsA.Alternatively, high levels of
RcsA might be inhibitoryto rcsA expression, leadingtoaself
limiting effect of the auto regulation.
In addition to the increase in rcsA90::lacZ expression and the
increased levels of RcsA protein in Alon cells, the levels of rcsA
mRNA increaseinthe absence of Lon proteaseas judged from
ribonuclease protection assays.The increase in detectable levels of
rcsA mRNA indicates that RcsA indeed activates rcsA transcription.
These observations are the first report of the involvement of RcsA
in activating the transcription of the rcsA gene.At least two other
Lon substrates, CcdA in E.coli (90) and 6G in B. subtilis (61) are
involved in regulating their own expression.Additionally, Gervais,
etal.(32) demonstratedthat RcsBisanactivator ofits own1 3 1
expression, and thereforethis mechanism of self activation might
be a conserved feature of the regulators of cpsexpression in E. coli.
The self activation of rcsA expression in the absence of Lon
protease was observed initiallyin Alonstrainsexpressingwild-
type RcsA protein.If this observation iscorrect, then presumably,
an increase in the expression levels of the rcsA90::lacZ fusion should
be observed in lon+rcsA* cells.The RcsA* mutants discussed
above were tested fortheirabilitytoactivate expression of the
rcsA90::lacZ fusion.rcsA90::lacZ expression increased inall five
mutants, indicating that the expression of the rcsA90::lacZ fusion is
increased whenever the levels of RcsA protein are increased, either
throughincreasedsynthesisfrom mutant promotersorthrough
increasedstabilitywithrespecttoLon dependentdegradation.
Additional support for the hypothesis presented here comes from
studies on the Lon dependent degradation of subunits of the HU
protein.Overexpression of either subunit of the HU protein (HUa
or HUM in E. coli lon+cells induces the expression of the cps genes
(81).This activation of cps expression was shown to be due to
activation of rcsA expression (81).Since individual HU subunits
representsubstratesforLon dependentdegradation(10),the
increase in rcsA expression can be explained with a stabilization of
RcsA due to saturation of Lon with either HU subunit, leading to
increased rcsA expression.1 3 2
A Conserved Sequence Motif Can Be Identified In The rcsA
And The cps PromoterRegions
From thedata presenteditappearsthat RcsAisindeed
involved in activating its own transcription: 1) levels of rcsA mRNA
increase in Alon cells, 2) expression levels of the rcsA90::lacZ fusion
increase in response to increased levels of RcsA, and 3) rcsA90::lacZ
expression levels are equally low in ion+ rcsA± and Alon 7-cc/v. cells
under conditions where no RcsA is present in the cells.Previously,
RcsA has been hypothesized to activate cps transcription.In order
for RcsA to regulate transcription of both cps and rcsA, the protein
hastointeractwiththe promoter regions of both thesegenes.
Binding of RcsA tothe promoter regions of these genes should
involve a nucleotide sequence conserved between the rcsA and the
cps promoter region.Such a region was identified by comparing
the promoter regions identified for both the rcsA gene (100) and
the cps genes (106).The putative "RcsA-Box" identified is 25 by
long and is 80% identical between the rcsA and the cps promoter.
Comparing the sequence of the putative "RcsA-Box" to the complete
genome of E. coli using the"fasta" search engine did not identify
any other putative "RcsA-Box" locations on the E. coli chromosome.
The "RcsA-Box" shows the longest stretch of identity on the 3' side
where a stretch of 12 by is 100% conserved.This stretch consists
of an inverted repeat of 6 bp, which might represent the binding
site for RcsA.In the cps promoter region, the putative RcsA-Box" is
located between position-91and -68 with respecttothec p s1 3 3
transcriptional startsite (106), whileitis located between position
-180 and -164 with respect to the rcsAtranscriptionalstartsite
(100).
RcsA bindingtoeitherpromoterregionhasnotbeen
demonstrated in vitro.The influence of this putative "RcsA-Box" on
the expression of both the rcsA and cpsgenes was measured using
transcriptional fusions either with or without the putative "RcsA-
Box".High level expression of the cps::lacZ fusion was dependent
on the presence of the "RcsA-Box" and the presence of RcsA and
RcsB in the cells.The truncated cps::lacZ fusion, missing the "RcsA-
Box" sequence, responded only weakly to the stabilization ofRcsA.
The increase seen with the cps fusion containing the "RcsA-Box" in
response to the stabilization of RcsA was not as dramatic as that
seen with the cpsBio::lacZ fusion.The difference in the expression
levels of these two fusions can possibly be explained by a titration
effect,the cpsBio::lacZ fusion represents the only copy of the
cps promoter in the cell, while the cps constructdescribedhere
was introduced at the Xatt site and represents a second copy of the
promoter region in addition to the wild-type cps promoter region.
Expressionofthecps genesisabsolutelydependentonthe
presence of RcsB; the cps::lacZ fusion containing the "RcsA-Box"
sequenceisonly expressed inthe presence of RcsA and RcsB,
indicating that the binding site for RcsB is located downstream of
position -68 of the cps promoter.As with the cps::lacZ fusion, the
effect of the "RcsA-Box" on the expression of the rcsA::lacZ fusions
was quite dramatic.The fusion containing the putative "RcsA-Box"134
responded to the stabilization of RcsA in a Mon strain with a 100
fold increase in expression, while expression of the rcsA::lacZ
fusion missing the putative "RcsA-Box" did not change in a A Ion
strain.The fact that the rcsA fusion lacking the "putative "RcsA-
Box" did not respond to the stabilization of RcsA is a very strong
indication for the binding of RcsA to the "RcsA-Box".The high
baseline expression of the rcsA fusion lacking the "RcsA-Box" is
similar to the high baseline expression of short rcsA::lacZ fusions
reportedbySledjeski, et al.with fusions of comparable length
(100) and was attributedtothe fact that these promoter regions
are not silenced by H-NS.Indeed, expression of the rcsA109::lacZ
fusion was not increased inan hns- strain(datanotshown).
Removal of the putative "RcsA-Box" might eliminate any regulatory
mechanism, positive and negative, imposed on rcsA expression, and
the level seen for the rcsA109::lacZ fusionmightrepresenta
constitutive level of rcsA expression.RcsA has been identified in
several other bacterial species (1,6,84).Sequence comparison of
the promoter regions of these rcsA genes to the sequence of the
putative "RcsA-Box" identified a region in the promoter region of
E. amylovora which is 80% identical to the putative "RcsA-Box" over
a 14 base pair stretch.The E. amylovora sequence consists of one
half of the inverted repeat found in the sequence of the E.coli
"RcsA-Box".No informationisavailable about a possibleself
activation of the E.amylovora rcsA gene.The data presented here
are a strong indication that the sequence motif conserved between1 3 5
the rcsA and the cps promoter region corresponds tothe binding
site for RcsA.
Involvement Of RcsB And H-NS In rcsAExpression
Theinvolvementof RcsA and RcsBinregulatingthe
expressionofrcsAisreminiscent of theregulationof cps
expression.To address the question if rcsA expression, in addition
to the silencing by H-NS, is regulated in a similar fashion as the
expression of cps expression levels of the rcsA90::lacZ fusion were
assessed instrains carrying mutations in either Ion, rcsB, hns or
combinations of these genes.The results of these studies indicate
that the effect of H-NS on the expression of rcsA is independent of
RcsB:a mutation in hns leads to a ten fold increase in rcsA90::lacZ
expression in the presence or absence of RcsB.The positive effect
of RcsB on rcsA expression is dependent on the presence of RcsA:
overproduction of RcsB from a multicopy plasmid in a Ion+ strain
does not lead to the activation of rcsA90::lacZ expression, possibly
due tothe absence of RcsA (data not shown).rcsA90::lacZ
expression is maximal in a strain mutant for lon.In this strain,
expression of the rcsA90::lacZ fusion is100 fold higher than that
seen in the wild-type strain, and the introduction of a mutation in
hns does not appear to significantly increase the expression levels
of the rcsA90::lacZ any further.In the absence of Lon, RcsB and H-
NS, the expression of the rcsA90::lacZfusion does not return to the
levels seen in the isogenic rcsB+ strain,indicatingthat RcsB is1 3 6
required for optimum rcsA expression.The data obtained do not
allow for determination of the effect of RcsB on rcsA expression: is
this effect at the transcriptional level or,isit because the presence
of RcsB increasesthestabilityof RcsA sufficientlytoallow
increased expression?The observationthat rcsAexpressionis
increased only10 foldinthetriple mutant strain,and thatthe
half-life of the RcsA protein in this strain isstill 30 minutes, similar
to the half-life of RcsA in a Alon rcsB+ strain, seems to indicate that
the effect of RcsB is at the transcriptional level.In Alon strains,the
levels of rcsA90::lacZ expression areparalleledinthelevels of
detectable RcsA protein.RcsA isdetectable only inthetriple
mutant (AlonrcsB- hns-) but not in any strain wild-type for ion,
independent of the expression levels of the rcsA90::lacZ fusion.
Interestingly, in a hns mutant, no RcsA protein is detectable, even
though the cells are mucoid.
Whatmightexplainthecomplexregulatorynetwork
governing rcsA expression and ultimately cps expression?The
production of the colanic acid capsule in E. coli has been implicated
in protection from desiccation and osmotic shock.An increase in
cps expression in response to osmotic shock was shown (101).The
increaseof cpsexpressioninthiscaseisinresponsetoan
environmental stimulus andtheactivationof cps expressionis
accomplished throughactivationof RcsB via RcsC.RcsAis
effectively degraded in a Lon dependent fashion, and in wild-type
cells RcsA protein is not available to participate in the activation of
cps expression.How can a cell accomplish maximal expression of1 3 7
the cps genes in a ion+background?Many genes underthe
negative control of H-NS are regulated in response to changes in
the environment (4,121).Changes in the pH or the osmolarity of
the medium, cold shock, entryintostationary phase, and other
factors have been shown to activate genes silenced by H-NS.The
exact mechanism by which H-NS functionsinthe regulation of
many of these genes remains unknown.Increased expression of
the cps genes has been demonstrated in response to osmotic shock
(101) and this increase was shown to be dependent on RcsA, RcsB
and RcsC.One can envision a mechanism in which the silencing of
rcsA by H-NS is removed, leading to increased expression of rcsA.
The level of RcsA in the cell increases to a point where the level of
RcsAsynthesisexceedsthelevelofLondependentRcsA
degradation allowing for the induction of cps expression.Capsule is
expressed as long as the stimulus persists.Once H-NS silencing is
reestablished,Lon canclear RcsA fromthesystemandc p s
expression isturned off.This regulatory patternis analogous to
the regulation of Su1A activity.sulAexpressionisde-repressed
upon SOS induction and levels of SulA protein increase to the point
where the protein cannot be completely eliminated from thecell.
This allows Su1A to carry out its function, inhibition of cell division,
until sulA expressionisagainrepressed,theproteiniscleared
from the cell and cell division can resume.
Thisproposedregulatory mechanism allowsforthefine
tuning of cps expression through two independent pathways.A
potential stimulus for the induction of rcsA expression has not yet1 3 8
been identified,butitcan be envisioned that maximum capsule
expression might be in response to a stimulus that activates both
pathwayssimultaneously.
Summary
ThestudiespresentedherehavedemonstratedthatLon
proteaserecognizesdifferentphysiologicalsubstrateswith
differentaffinities.Furthermore,theaffinitiesof thesubstrates
appears to be dependent on their biological role,proteins whose
stabilization has a negative effect on the survival of E. coli (S ul A)
aredegradedwithahighaffinity,whilesubstrateswhose
persistenceisbeneficial are degraded with lower affinity (RcsA,
CcdA).
A mutation of methionine 145 can stabilize RcsA protein in
the presence of Lon protease and RcsB.In the absence of RcsB, this
mutant RcsA protein cannot be detected, possibly due to a lack of
rcsA expression in a strain mutant for rcsB.
RcsA functionsasanactivatorofitsown transcription;
stabilization increases expression of RcsA up to100 fold.This
increase is dependent on the presence of RcsB.RcsB's function as
an auxiliary to rcsAtranscriptionisdependent on RcsA,since
overexpression of RcsB ina lon+ strain does not increase rcsA
expression.The effect of RcsA and RcsB on the activation of rcsA
expression is independent of H-NS.1 3 9
A conserved sequence motif inthe promoter region of the
rcsA and the cps genes was identified which appears to function as
a binding site of RcsA.
Thenewlyidentifiedregulatorymechanismforthe
expression of rcsA might represent a mechanism which allows E.
coli to increase cps gene expression independent of the RcsB/RcsC
pathway.Alternatively,thestimulationof both pathways may
leadtomaximal expressionofthecps genesundercertain
conditions.140
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